https://simplecast.com Healthcare Weekly: At the Forefront of Healthcare Innovation How is technology reshaping the healthcare industry? The Healthcare Weekly podcast reframes the conversation about the delivery of care in the US and beyond. Join hosts Codrin Arsene and Michael Reddy as they interview the best & brightest in healthcare to explore how new innovations — including artificial intelligence, blockchain, virtual reality and big data — are improving patient outcomes and changing the healthcare experience. @2019 Healthcare Weekly Podcast en Tue, 14 Mar 2023 05:00:00 +0000 Tue, 14 Mar 2023 05:00:11 +0000 http://www.healthcareweekly.com Healthcare Weekly: At the Forefront of Healthcare Innovation https://image.simplecastcdn.com/images/6bd1f9ec-fedd-4072-a1f0-0b113afde91f/233b6275-83f8-48d4-9fdf-555ee1062ddd/3000x3000/1551227357-artwork.jpg?aid=rss_feed http://www.healthcareweekly.com episodic How is technology reshaping the healthcare industry? The Healthcare Weekly podcast reframes the conversation about the delivery of care in the US and beyond. Join hosts Codrin Arsene and Michael Reddy as they interview the best & brightest in healthcare to explore how new innovations — including artificial intelligence, blockchain, virtual reality and big data — are improving patient outcomes and changing the healthcare experience. Codrin Arsene, Michael Reddy no https://feeds.simplecast.com/_IqAcTwN healthtech, healthcare technology, healthcare innovation Codrin S Arsene codrin.arsene@digitalauthority.me 8ce9e2db-b6f8-4f3c-a74e-3d1e10791df5 Fertility Monitoring Using Body Temperature and an App Learn more about Natural Cycles here.

]]> Tue, 14 Mar 2023 05:00:00 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Natural Cycles here.

]]> Fertility Monitoring Using Body Temperature and an App Codrin S Arsene 00:31:45 Today Codrin is joined by Raoul Sherwitzl, the co-founder of Natural Cycles, a mobile app for contraception and fertility monitoring. Raoul and his wife developed the concept together while researching non-hormonal, non-invasive alternatives to the traditional birth control they were used to. Unsatisfied with their options, they set about developing an app that would predict ovulation using only data input from the user. Natural Cycles uses daily body temperature readings to assess whether a woman is at risk of pregnancy on a particular day. As an entirely non-invasive option, Natural Cycles also offers the unique benefit of having zero risk of side effects. Raoul lets us in on his plans for the future of this software and the technology associated with it. He intends on making the app more accessible and furthering the technology to create a better user experience. Ultimately, he would like to expand the services offered by Natural Cycles, creating and accessible and easy-to-use software that supports women’s health overall. Listen to the podcast to learn about: • The science behind how Natural Cycles accurately predicts ovulation. • How Natural Cycles has changed fertility monitoring for its users. • Benefits of using an app as opposed to traditional methods of birth control. • How algorithm-based technology could change the future of health care. • The challenge of creating a product for which there are no existing regulations in place. • How the accessibility of birth control ties into greater issues, such as climate change. • The importance of transparency when marketing healthcare products. • Raoul’s immediate plans for updates to Natural Cycles. Today Codrin is joined by Raoul Sherwitzl, the co-founder of Natural Cycles, a mobile app for contraception and fertility monitoring. Raoul and his wife developed the concept together while researching non-hormonal, non-invasive alternatives to the traditional birth control they were used to. Unsatisfied with their options, they set about developing an app that would predict ovulation using only data input from the user. Natural Cycles uses daily body temperature readings to assess whether a woman is at risk of pregnancy on a particular day. As an entirely non-invasive option, Natural Cycles also offers the unique benefit of having zero risk of side effects. Raoul lets us in on his plans for the future of this software and the technology associated with it. He intends on making the app more accessible and furthering the technology to create a better user experience. Ultimately, he would like to expand the services offered by Natural Cycles, creating and accessible and easy-to-use software that supports women’s health overall. Listen to the podcast to learn about: • The science behind how Natural Cycles accurately predicts ovulation. • How Natural Cycles has changed fertility monitoring for its users. • Benefits of using an app as opposed to traditional methods of birth control. • How algorithm-based technology could change the future of health care. • The challenge of creating a product for which there are no existing regulations in place. • How the accessibility of birth control ties into greater issues, such as climate change. • The importance of transparency when marketing healthcare products. • Raoul’s immediate plans for updates to Natural Cycles. no full 56 e0087154-6445-46b6-b251-712a458832d0 How Fast is the Dental Industry Evolving? Learn more about Premier Dental Products: https://www.premierdentalco.com/

]]> Tue, 28 Feb 2023 06:00:00 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Premier Dental Products: https://www.premierdentalco.com/

]]> How Fast is the Dental Industry Evolving? Codrin S Arsene 00:23:23 Julie Charlestein is welcomed by Codrin in this episode. She is the President and CEO of Premier Dental Products, a company that develops, manufactures, and distributes innovative solutions for dentists around the world. There are many technological advances currently available to dentists, but Julie explains that the adoption of these has brought mixed results. We hear Julie’s thought on gender representation in her industry as well as the history of her business. It was founded by her family, but she first gained her insights by observing the company from the outside. Premier Dental Products leverages a large amount of customer data to optimize their products. Julie gives us some insights to this process, including how new product needs can be identified. Listen to the podcast to learn about: • How dentist offices are like mini tech centers. • Trends being seen right now in the dental space. • Traxodent, a flagship product offered by Premier Dental Products. • A product that has seen an uptick in popularity during COVID-19. • The collaborative relationship that used to exist in this space. • Data that the company collects and how it is leveraged. • Determining the likelihood of product adaptation using artificial intelligence. • Getting data on how products are used when they are sold by a distributor. • Looking at holes in the marketplace. • Upcoming trends that Julie thinks will influence her company in the next decade. • What we can get excited about as dental consumers. Julie Charlestein is welcomed by Codrin in this episode. She is the President and CEO of Premier Dental Products, a company that develops, manufactures, and distributes innovative solutions for dentists around the world. There are many technological advances currently available to dentists, but Julie explains that the adoption of these has brought mixed results. We hear Julie’s thought on gender representation in her industry as well as the history of her business. It was founded by her family, but she first gained her insights by observing the company from the outside. Premier Dental Products leverages a large amount of customer data to optimize their products. Julie gives us some insights to this process, including how new product needs can be identified. Listen to the podcast to learn about: • How dentist offices are like mini tech centers. • Trends being seen right now in the dental space. • Traxodent, a flagship product offered by Premier Dental Products. • A product that has seen an uptick in popularity during COVID-19. • The collaborative relationship that used to exist in this space. • Data that the company collects and how it is leveraged. • Determining the likelihood of product adaptation using artificial intelligence. • Getting data on how products are used when they are sold by a distributor. • Looking at holes in the marketplace. • Upcoming trends that Julie thinks will influence her company in the next decade. • What we can get excited about as dental consumers. no full 55 704f6fd4-a0c8-4024-85f0-fd9a12d8132a What Applications Does AR Have in Healthcare? Learn more about ThirdEye: https://www.thirdeyegen.com

]]> Tue, 14 Feb 2023 06:00:00 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about ThirdEye: https://www.thirdeyegen.com

]]> What Applications Does AR Have in Healthcare? Codrin S Arsene 00:34:19 Today’s guest is Nick Cherukuri, Founder and CEO of ThirdEye, a company providing augmented reality glasses. ThirdEye was founded in 2016 and has seen rapid growth as a provider of all in one augmented reality solutions for all industries. In the case of the healthcare space, ThirdEye aims to provide hands free working for medical professionals, allowing workers in the field to remotely connect to experts and access protocols and patient information. Nick joins us today to discuss the many possible applications for AR in healthcare, how ThirdEye has avoided the fate of Google Glass and the scope for using AR as a chronic disease management tool. Listen to the podcast to learn about: • How ThirdEye came to be • Specific use cases for AR in healthcare • The benefits of hands-free working in the medical field • Telehealth applications of ThirdEye technology • Avoiding the fate of Google Glass • Creating the ability to triage at a distance • Improving safety and efficiency for workers • Integration with existing healthcare systems • Human factor issues in using ThirdEye technology • User face and intractability options • Current healthcare applications and opportunities • Going past gadgets to becoming useful technology • Use cases for quality of life improvement • Scope for chronic disease management in AR • The beneficial features of ThirdEye products • Pricing options and programs • Where ThirdEye is going in the next five to ten years • Future possibilities for AR integration in healthcare Today’s guest is Nick Cherukuri, Founder and CEO of ThirdEye, a company providing augmented reality glasses. ThirdEye was founded in 2016 and has seen rapid growth as a provider of all in one augmented reality solutions for all industries. In the case of the healthcare space, ThirdEye aims to provide hands free working for medical professionals, allowing workers in the field to remotely connect to experts and access protocols and patient information. Nick joins us today to discuss the many possible applications for AR in healthcare, how ThirdEye has avoided the fate of Google Glass and the scope for using AR as a chronic disease management tool. Listen to the podcast to learn about: • How ThirdEye came to be • Specific use cases for AR in healthcare • The benefits of hands-free working in the medical field • Telehealth applications of ThirdEye technology • Avoiding the fate of Google Glass • Creating the ability to triage at a distance • Improving safety and efficiency for workers • Integration with existing healthcare systems • Human factor issues in using ThirdEye technology • User face and intractability options • Current healthcare applications and opportunities • Going past gadgets to becoming useful technology • Use cases for quality of life improvement • Scope for chronic disease management in AR • The beneficial features of ThirdEye products • Pricing options and programs • Where ThirdEye is going in the next five to ten years • Future possibilities for AR integration in healthcare no full 53 1f043997-9fe8-4a59-9488-28a421305e8b Data Science in Healthcare Learn more about RediMinds here: https://rediminds.com

]]> Wed, 8 Feb 2023 06:00:00 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about RediMinds here: https://rediminds.com

]]> Data Science in Healthcare Codrin S Arsene 00:27:05 Today’s guest is Madhu Reddiboina, CEO of RediMinds Inc. This company is in the data sciences field aiming to improve the healthcare delivery through data acquisition and analysis. RediMinds specialize in collecting and organizing all patient centric clinical modalities, problem-specific data integration, and feature engineering. Their models augment the physician’s ability to predict disease vectors and effectively administer treatment protocols. We hear about what data science is and how it can be used in the healthcare space, the issue of explainability when it comes to AI, and the hinderances to interoperability in the current system. Listen to the podcast to learn about: • What data science is • The scope of the applications of data science in healthcare • The process of ‘digitizing’ the patient journey and how it can create predictability models • What the current extent of data science utilization is in the healthcare system • Mechanisms of building predictability models • How RediMinds validates their AI models • The issue of Explainability • Lack of interoperability in the current healthcare system • Creating a better understanding of disease through data science • Fragmentation issues in the healthcare data space • How the fear of new technology and liability hinders adoption rates • The potential role of data science in healthcare over the next decade • The future of RediMinds Today’s guest is Madhu Reddiboina, CEO of RediMinds Inc. This company is in the data sciences field aiming to improve the healthcare delivery through data acquisition and analysis. RediMinds specialize in collecting and organizing all patient centric clinical modalities, problem-specific data integration, and feature engineering. Their models augment the physician’s ability to predict disease vectors and effectively administer treatment protocols. We hear about what data science is and how it can be used in the healthcare space, the issue of explainability when it comes to AI, and the hinderances to interoperability in the current system. Listen to the podcast to learn about: • What data science is • The scope of the applications of data science in healthcare • The process of ‘digitizing’ the patient journey and how it can create predictability models • What the current extent of data science utilization is in the healthcare system • Mechanisms of building predictability models • How RediMinds validates their AI models • The issue of Explainability • Lack of interoperability in the current healthcare system • Creating a better understanding of disease through data science • Fragmentation issues in the healthcare data space • How the fear of new technology and liability hinders adoption rates • The potential role of data science in healthcare over the next decade • The future of RediMinds no full 52 7c9539fe-39f1-4a77-b15e-2c9696fd7b3c How Can AI Help with Earlier Detection of Disease? Learn more about Medial EarlySign: https://earlysign.com

]]> Mon, 6 Dec 2021 21:44:13 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Medial EarlySign: https://earlysign.com

]]> How Can AI Help with Earlier Detection of Disease? Codrin S Arsene 00:35:19 Today’s guest is Dr. Jeremy Orr, CEO and Chief Medical Officer of Medial EarlySign, a company that hopes to create widespread AI and machine learning integration in diagnostics. Medial EarlySign aims to help their clients deliver better patient care by identifying individuals at risk of high burden disease who might benefit from the earlier detection of deterioration trajectories. They are leading the charge in augmenting healthcare providers and increasing automation in healthcare delivery. Dr. Orr joins us to discuss applying machine learning techniques to clinical data, how the success of their algorithms is measured, and the impediments they face in expanding AI adoption. Listen to the podcast to learn about: • What Medial EarlySign does • Applying machine learning techniques to clinical data • The Medial EarlySign mission: Aiming for early detection • The process of validating algorithms • FDA classification and interactions • The accuracy percentage of their current algorithm • How they aim to augment healthcare providers, not replace them • The process of incorporating more machine learning into diagnostics • How AI can impact chronic condition management • Friction points and resistance to AI • The importance of individualised, smooth workflow integration • Creating trust in machine learning • The high standards AI is held to and how it can cause distrust • Impediments to expanding adoption • The future of Medial EarlySign and machine learning in healthcare Today’s guest is Dr. Jeremy Orr, CEO and Chief Medical Officer of Medial EarlySign, a company that hopes to create widespread AI and machine learning integration in diagnostics. Medial EarlySign aims to help their clients deliver better patient care by identifying individuals at risk of high burden disease who might benefit from the earlier detection of deterioration trajectories. They are leading the charge in augmenting healthcare providers and increasing automation in healthcare delivery. Dr. Orr joins us to discuss applying machine learning techniques to clinical data, how the success of their algorithms is measured, and the impediments they face in expanding AI adoption. Listen to the podcast to learn about: • What Medial EarlySign does • Applying machine learning techniques to clinical data • The Medial EarlySign mission: Aiming for early detection • The process of validating algorithms • FDA classification and interactions • The accuracy percentage of their current algorithm • How they aim to augment healthcare providers, not replace them • The process of incorporating more machine learning into diagnostics • How AI can impact chronic condition management • Friction points and resistance to AI • The importance of individualised, smooth workflow integration • Creating trust in machine learning • The high standards AI is held to and how it can cause distrust • Impediments to expanding adoption • The future of Medial EarlySign and machine learning in healthcare no full 51 c47e549e-a47f-4b64-87a9-8bb6cc69ec91 Transforming the Medical Industry from within: Health2047, an AMA company Learn more about Health2047’s services here.

]]> Sun, 6 Dec 2020 14:03:02 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Health2047’s services here.

]]> Transforming the Medical Industry from within: Health2047, an AMA company Codrin S Arsene 00:33:43 On today’s episode of Healthcare Weekly, Larry Cohen, the CEO of Health 2047 talks about his company’s goal to transform the medical industry from the ground up. Health2047 focuses on four main groups: data liquidity, chronic care, radical productivity, and healthcare value. They tackle some of the biggest healthcare challenges in partnership with the American Medical Association (AMA), the parent company of Health2047. Why the name Health2047? Because in 2047, America will lead the world in all major healthcare metrics. This company has some huge goals and they are well on their way to achieving them. Listen to this episode to learn about: • What Health2047 does and how the AMA plays a part in the company. • How does Health2047 work and how is it structured? • The four companies involved with Health2047 and their roles. • Who should reach out to have an exploratory conversation with Health2047. • The advancement of digital services assisting senior citizens. • The biggest hurdles to overcome when launching a new technological solution for physicians. • Some of the concerns that come up from a physician’s perspective when adopting new technologies. • Health2047’s plan to announce one major partnership per quarter. How does that work? • The most exciting trends that’s changing the healthcare system. On today’s episode of Healthcare Weekly, Larry Cohen, the CEO of Health 2047 talks about his company’s goal to transform the medical industry from the ground up. Health2047 focuses on four main groups: data liquidity, chronic care, radical productivity, and healthcare value. They tackle some of the biggest healthcare challenges in partnership with the American Medical Association (AMA), the parent company of Health2047. Why the name Health2047? Because in 2047, America will lead the world in all major healthcare metrics. This company has some huge goals and they are well on their way to achieving them. Listen to this episode to learn about: • What Health2047 does and how the AMA plays a part in the company. • How does Health2047 work and how is it structured? • The four companies involved with Health2047 and their roles. • Who should reach out to have an exploratory conversation with Health2047. • The advancement of digital services assisting senior citizens. • The biggest hurdles to overcome when launching a new technological solution for physicians. • Some of the concerns that come up from a physician’s perspective when adopting new technologies. • Health2047’s plan to announce one major partnership per quarter. How does that work? • The most exciting trends that’s changing the healthcare system. larry cohen, digital incubators in healthcare, health2047, healthcare startups no full 50 6e5d921e-9d46-4103-891c-336c67ddac26 Digital Transformation in Clinical Trials: Options & Opportunities Learn more about Medidata: https://www.medidata.com/en/

]]> Sun, 6 Dec 2020 11:46:21 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Medidata: https://www.medidata.com/en/

]]> Digital Transformation in Clinical Trials: Options & Opportunities Codrin S Arsene 00:47:45 Today’s guest is Glen de Vries. He is Co-CEO and Co-Founder of Medidata, a platform for professionals and patients involved in clinical trials to simply and comprehensively collect data. Medidata is the most used platform for clinical trials in the world and has powered tens of thousands of trails, with millions of patients and billions of patient records. Medidata aims to create and improve precision medicine by utilizing data collected in clinical trials to improve treatment protocols. Glen discusses the importance of the patient experience when collecting data, how clinical trial management protocols are changing with technological innovations, and how digital transformation can help transform the healthcare system. Listen to the podcast to learn about: • How Medidata began as a platform to connect life sciences professionals • How the Medidata platform allows for greater patient engagement and connection to research • How Medidata has created a fully interactive experience • Clinical trial protocols and how they are changing with advancements in technology • The importance of aiding and administering precision medicine • ‘Patient Equation’: what it is and how it works • Data collection and analysis in modern clinical trials • How health systems can break down data silos • Opportunities for data collection and utilization during COVID-19 • The process of simplifying and consolidating data collection • How technology could impact the future management of trials • Future predictions for precision medicine Today’s guest is Glen de Vries. He is Co-CEO and Co-Founder of Medidata, a platform for professionals and patients involved in clinical trials to simply and comprehensively collect data. Medidata is the most used platform for clinical trials in the world and has powered tens of thousands of trails, with millions of patients and billions of patient records. Medidata aims to create and improve precision medicine by utilizing data collected in clinical trials to improve treatment protocols. Glen discusses the importance of the patient experience when collecting data, how clinical trial management protocols are changing with technological innovations, and how digital transformation can help transform the healthcare system. Listen to the podcast to learn about: • How Medidata began as a platform to connect life sciences professionals • How the Medidata platform allows for greater patient engagement and connection to research • How Medidata has created a fully interactive experience • Clinical trial protocols and how they are changing with advancements in technology • The importance of aiding and administering precision medicine • ‘Patient Equation’: what it is and how it works • Data collection and analysis in modern clinical trials • How health systems can break down data silos • Opportunities for data collection and utilization during COVID-19 • The process of simplifying and consolidating data collection • How technology could impact the future management of trials • Future predictions for precision medicine clinical trial management, clinical trials, healthcare digital transformation, personalized medicine no full 49 fbc23e05-0c3b-4652-ba3a-c05b51db496c Using CollaborNet to Deliver Optimal Patient Care You can learn more about Holon Solutions here

]]> Sun, 6 Dec 2020 11:19:10 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com You can learn more about Holon Solutions here

]]> Using CollaborNet to Deliver Optimal Patient Care Codrin S Arsene 00:30:00 On today’s episode we are joined by Jon Zimmerman, the CEO of Holon Solutions. Holon Solutions has built a patented technology software, CollaborNet®, which provides healthcare practices with patient insights so that they can focus on delivering optimal patient care. Jon has over 35 years in the healthcare industry and was part of pioneering Electronic Data Interchange (EDI) process which can be used by companies to share data securely in an electronic format in the late 1980s. In 2014, he received the Louis J. Sullivan Award from the Workgroup for Electronic Data Interchange (WEDI) for his continued efforts in making the healthcare industry more efficient. Listen to this episode to hear more on: • What Holon Solutions does and how their solution fits into the bigger picture of data accessibility in healthcare • How physicians interact with the Holon Solutions platform • How Holon Solutions provide insights that assist the diagnosis process. • If the platform has experienced pushback from physicians based on user compatibility • The return on investment (ROI) by using the software • Metrics for adopting CollaborNet • Gaps in medical coding and how the platform addresses them • What hospital systems can expect if they invest in working long-term with Holon Solutions On today’s episode we are joined by Jon Zimmerman, the CEO of Holon Solutions. Holon Solutions has built a patented technology software, CollaborNet®, which provides healthcare practices with patient insights so that they can focus on delivering optimal patient care. Jon has over 35 years in the healthcare industry and was part of pioneering Electronic Data Interchange (EDI) process which can be used by companies to share data securely in an electronic format in the late 1980s. In 2014, he received the Louis J. Sullivan Award from the Workgroup for Electronic Data Interchange (WEDI) for his continued efforts in making the healthcare industry more efficient. Listen to this episode to hear more on: • What Holon Solutions does and how their solution fits into the bigger picture of data accessibility in healthcare • How physicians interact with the Holon Solutions platform • How Holon Solutions provide insights that assist the diagnosis process. • If the platform has experienced pushback from physicians based on user compatibility • The return on investment (ROI) by using the software • Metrics for adopting CollaborNet • Gaps in medical coding and how the platform addresses them • What hospital systems can expect if they invest in working long-term with Holon Solutions no full 48 974cf537-132d-4ab7-8418-a836a2141939 How Self-Insured Employers Can Get Amazing Health Coverage & Control Costs At The Same Time Learn more about RxBenefits: https://www.rxbenefits.com/

]]> Sun, 27 Sep 2020 11:35:09 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Bryan Statham) http://www.healthcareweekly.com Learn more about RxBenefits: https://www.rxbenefits.com/

]]> How Self-Insured Employers Can Get Amazing Health Coverage & Control Costs At The Same Time Codrin Arsene, Bryan Statham 00:45:11 This week on the Healthcare Weekly podcast, Codrin Arsene interviewed Bryan Statham. He is the CEO of RxBenefits, a pharmacy adviser to employee benefits consultants and an established pharmacy benefits solution provider for self-insured employers. The company was founded in 1995 and Bryan began working there in 2005. This episode gets stated by discussing the difference between a PBM and a PBO. We hear about 3 things self-insured companies should look for when negotiating benefits coverage options for their employees: the contract, clinical elements, and the service. The employees of RxBenefits work as a health insurance accountant: they read over contracts, make suggestions, and help employers optimize their benefits plan. Bryan explains that some of the big benefits providers sometimes use tactics trying to upsell employers. They may offer an add-on, preying on the employers’ lack of knowledge to tell them that they require more than they really do. Companies must do their due diligence before settling on a plan. Listen to the podcast to learn about: • The difference between a PBM and a PBO. • 3 things companies who are self-insured should look for in their benefits coverage. • How companies can negotiate the price of a healthcare coverage contract and optimize cost over time without reducing quality of care. • What the employees of RxBenefits do. • How big benefits providers sometimes prey on employers’ lack of knowledge. • The value and importance of understanding health benefits coverage offered under an insurance plan This week on the Healthcare Weekly podcast, Codrin Arsene interviewed Bryan Statham. He is the CEO of RxBenefits, a pharmacy adviser to employee benefits consultants and an established pharmacy benefits solution provider for self-insured employers. The company was founded in 1995 and Bryan began working there in 2005. This episode gets stated by discussing the difference between a PBM and a PBO. We hear about 3 things self-insured companies should look for when negotiating benefits coverage options for their employees: the contract, clinical elements, and the service. The employees of RxBenefits work as a health insurance accountant: they read over contracts, make suggestions, and help employers optimize their benefits plan. Bryan explains that some of the big benefits providers sometimes use tactics trying to upsell employers. They may offer an add-on, preying on the employers’ lack of knowledge to tell them that they require more than they really do. Companies must do their due diligence before settling on a plan. Listen to the podcast to learn about: • The difference between a PBM and a PBO. • 3 things companies who are self-insured should look for in their benefits coverage. • How companies can negotiate the price of a healthcare coverage contract and optimize cost over time without reducing quality of care. • What the employees of RxBenefits do. • How big benefits providers sometimes prey on employers’ lack of knowledge. • The value and importance of understanding health benefits coverage offered under an insurance plan benefits managers, health insurance, healthcare costs, self-insured employers no full 54 0ed53918-8ce8-4bbf-a8cf-c9de1e3d6fe1 Same Medical Procedure, Same Hospital, Different Costs: Why and What You Can Do About It? Learn more about Healthcare Bluebook: https://www.healthcarebluebook.com

]]> Tue, 22 Sep 2020 13:52:39 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Michael O’Neil) http://www.healthcareweekly.com Learn more about Healthcare Bluebook: https://www.healthcarebluebook.com

]]> Same Medical Procedure, Same Hospital, Different Costs: Why and What You Can Do About It? Codrin Arsene, Michael O’Neil 00:52:04 Today’s guest is Michael O’Neil, Sr. Vice President of Strategy & Development for Healthcare Bluebook. Healthcare Bluebook, started in 2007, is a digital platform that combines objective price and quality data with industry-leading usability helping employers and employees get the best price for their upcoming medical procedure. Healthcare Bluebook provides people and organizations with everything they need to be more effective healthcare consumers. Michael joins us today to discuss the lack of transparency in the American healthcare system and how his company has established a streamlined rating system of healthcare options to help patients decide where to have their next medical procedure done. Listen to the podcast to learn about: • What Healthcare Bluebook does • The difference between actual cost and billed charges in healthcare • Price transparency problems in the US health system • Why transparency is such a big issue in healthcare • How the health system is geared to benefit payers • Why profit caps for payers has driven up treatment costs • Why self-insured employers could be the best bet for driving change in healthcare price transparency • Cherry picking which provider is best and identifying who is worst for your next medical procedure • How Healthcare Bluebook made data around medical procedures easily digestible for consumers • The future of price discrepancy and price transparency Today’s guest is Michael O’Neil, Sr. Vice President of Strategy & Development for Healthcare Bluebook. Healthcare Bluebook, started in 2007, is a digital platform that combines objective price and quality data with industry-leading usability helping employers and employees get the best price for their upcoming medical procedure. Healthcare Bluebook provides people and organizations with everything they need to be more effective healthcare consumers. Michael joins us today to discuss the lack of transparency in the American healthcare system and how his company has established a streamlined rating system of healthcare options to help patients decide where to have their next medical procedure done. Listen to the podcast to learn about: • What Healthcare Bluebook does • The difference between actual cost and billed charges in healthcare • Price transparency problems in the US health system • Why transparency is such a big issue in healthcare • How the health system is geared to benefit payers • Why profit caps for payers has driven up treatment costs • Why self-insured employers could be the best bet for driving change in healthcare price transparency • Cherry picking which provider is best and identifying who is worst for your next medical procedure • How Healthcare Bluebook made data around medical procedures easily digestible for consumers • The future of price discrepancy and price transparency medical procedure, surgery costs, healthcare costs no full 47 f05ab0dc-1f4f-431e-ae3c-15c4c588978b [Podcast] AI And Interoperability in Healthcare: Current Applications, Challenges and Predictions Interested in learning more? You can check out Apixio here.

]]> Tue, 22 Sep 2020 12:58:51 +0000 codrin.arsene@digitalauthority.me (Darren Schulte, Codrin Arsene) http://www.healthcareweekly.com Interested in learning more? You can check out Apixio here.

]]> [Podcast] AI And Interoperability in Healthcare: Current Applications, Challenges and Predictions Darren Schulte, Codrin Arsene 01:01:02 Darren Schulte, CEO of Apixio, joins Codrin Arsene to talk about the present and future of artificial intelligence in healthcare in this episode of the Healthcare Weekly Podcast. Founded in 2009, Apixio is a data science and advanced analytics company dedicated to unlocking actionable, relevant and timely insights for health providers all over the US. Apixio uses a patented computing platform that analyzes health records and gives a deep insight into patient health. A big problem in the healthcare industry is getting a complete picture of a patient’s overall health from available data sources (electronic medical records, surveys, questionnaires and more). This is the crux of why interoperability in the healthcare system remains more of a myth, so far, than a tangible reality. Apixio is trying to fix this issue. Listen to this episode to hear more on: • Why the current healthcare system is broken when it comes to interoperability • Information gap between physicians and specialists and how this affects diagnostics and ongoing care regimen for patients. • How artificial intelligence can completely redefine the healthcare industry - and indeed it’s doing so as we speak. • Why have we not made more progress when it comes to AI adoption in the healthcare space? • Do we have the infrastructure in place to make AI work for the healthcare industry? • Industry changes required to further support the adoption of artificial intelligence at scale. Darren Schulte, CEO of Apixio, joins Codrin Arsene to talk about the present and future of artificial intelligence in healthcare in this episode of the Healthcare Weekly Podcast. Founded in 2009, Apixio is a data science and advanced analytics company dedicated to unlocking actionable, relevant and timely insights for health providers all over the US. Apixio uses a patented computing platform that analyzes health records and gives a deep insight into patient health. A big problem in the healthcare industry is getting a complete picture of a patient’s overall health from available data sources (electronic medical records, surveys, questionnaires and more). This is the crux of why interoperability in the healthcare system remains more of a myth, so far, than a tangible reality. Apixio is trying to fix this issue. Listen to this episode to hear more on: • Why the current healthcare system is broken when it comes to interoperability • Information gap between physicians and specialists and how this affects diagnostics and ongoing care regimen for patients. • How artificial intelligence can completely redefine the healthcare industry - and indeed it’s doing so as we speak. • Why have we not made more progress when it comes to AI adoption in the healthcare space? • Do we have the infrastructure in place to make AI work for the healthcare industry? • Industry changes required to further support the adoption of artificial intelligence at scale. interoperability, ai in healthcare no full 46 50a5757a-8941-4eef-95c5-abfe3435b214 Technology & Preterm Infant Care Learn more about Astarte Medical here: https://astartemedical.com

]]> Mon, 14 Sep 2020 14:07:52 +0000 codrin.arsene@digitalauthority.me (Tracy Wrren, Codrin Arsene) http://www.healthcareweekly.com Learn more about Astarte Medical here: https://astartemedical.com

]]> Technology & Preterm Infant Care Tracy Wrren, Codrin Arsene 00:38:55 Today’s guest is Tracy Warren, CEO and Co-Founder of Astarte Medical. Astarte Medical is a precision medicine company using software and predictive analytics to improve preterm infant outcomes. Astarte utilizes data collected during treatment of preterm infants to help caregivers create treatment protocols based on optimizing the health of the microbiome within the first 1000 days of life. They offer the NICUtrition platform that allows professionals to streamline their process and have easy access to patient data. Tracy is here to discuss the impact nutrition has on the first 1000 days of life for preterm babies, how their platform utilizes data to create predictions and how much the cost of preterm care can be alleviated by using their software. Listen to the podcast to learn about: • What Astarte Medical aims to do • How they hope to impact long-term healthcare by focusing on the microbiome • What happens in terms of care after a baby is born prematurely • Understanding the specific needs of preterm babies • Challenges involved with preterm health • What causes growth rate failure in preterm infants • How hospitals deal with the issues surrounding preterm healthcare today • How staff interact with the NICUtrition platform • The benefits of having consolidated data • The process of setting protocols based on collected data sets • The cost of preterm care and how utilizing NICUtrition can alleviate some of it • Re-admittance rates of preterm infants • The importance of early pregnancy education regarding nutrition • The most important technology that could improve healthcare delivery • Addressing healthcare inequality Today’s guest is Tracy Warren, CEO and Co-Founder of Astarte Medical. Astarte Medical is a precision medicine company using software and predictive analytics to improve preterm infant outcomes. Astarte utilizes data collected during treatment of preterm infants to help caregivers create treatment protocols based on optimizing the health of the microbiome within the first 1000 days of life. They offer the NICUtrition platform that allows professionals to streamline their process and have easy access to patient data. Tracy is here to discuss the impact nutrition has on the first 1000 days of life for preterm babies, how their platform utilizes data to create predictions and how much the cost of preterm care can be alleviated by using their software. Listen to the podcast to learn about: • What Astarte Medical aims to do • How they hope to impact long-term healthcare by focusing on the microbiome • What happens in terms of care after a baby is born prematurely • Understanding the specific needs of preterm babies • Challenges involved with preterm health • What causes growth rate failure in preterm infants • How hospitals deal with the issues surrounding preterm healthcare today • How staff interact with the NICUtrition platform • The benefits of having consolidated data • The process of setting protocols based on collected data sets • The cost of preterm care and how utilizing NICUtrition can alleviate some of it • Re-admittance rates of preterm infants • The importance of early pregnancy education regarding nutrition • The most important technology that could improve healthcare delivery • Addressing healthcare inequality preterm care, pregnancy care no full 45 0d9ae250-2cfa-407b-a4de-2db36db87e4f Can We Predict Future Healthcare Risks? Learn more about Cotiviti’s services here.

]]> Sun, 6 Sep 2020 12:33:09 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Cotiviti’s services here.

]]> Can We Predict Future Healthcare Risks? Codrin S Arsene 00:28:41 On today’s episode of Healthcare Weekly, we are talking to Rachel Jones, Vice President of Cotiviti, a software company that leverages unparalleled clinical and financial datasets to deliver deep insight into the performance of the healthcare system. Cotiviti’s main focus is on payments, risk and quality. Understanding health plans is increasingly difficult for self insured employers, insurance brokers and even third party administrators. Cotiviti helps all these agents ensure they are getting the best quality of care at the most affordable cost, both as a healthcare payer and member. Listen to this episode to hear more about: • An in-depth look at how Cotiviti works. • How Insights and Analytics Can Provide Better Health Plan Options to Patients and Employers • How COVID-19 is affecting healthcare practices and services. • The increase in telehealth utilization and the cost shift from in-person services - and what it means for doctors and employers. • How back-to-school typically affects healthcare and what employers can do about it. • How Cotiviti can spotlight to predict future healthcare risks. • Cotiviti’s COVID-19 tracker and how it can uncover patterns and actionable insights. • How Cotiviti provides an online tool for everyone to uncover COVID-19 concentrations by state and county level and find out the next hotspots. • What Rachel thinks the main trends in healthtech are and how they’re helping shape the “new normal”. On today’s episode of Healthcare Weekly, we are talking to Rachel Jones, Vice President of Cotiviti, a software company that leverages unparalleled clinical and financial datasets to deliver deep insight into the performance of the healthcare system. Cotiviti’s main focus is on payments, risk and quality. Understanding health plans is increasingly difficult for self insured employers, insurance brokers and even third party administrators. Cotiviti helps all these agents ensure they are getting the best quality of care at the most affordable cost, both as a healthcare payer and member. Listen to this episode to hear more about: • An in-depth look at how Cotiviti works. • How Insights and Analytics Can Provide Better Health Plan Options to Patients and Employers • How COVID-19 is affecting healthcare practices and services. • The increase in telehealth utilization and the cost shift from in-person services - and what it means for doctors and employers. • How back-to-school typically affects healthcare and what employers can do about it. • How Cotiviti can spotlight to predict future healthcare risks. • Cotiviti’s COVID-19 tracker and how it can uncover patterns and actionable insights. • How Cotiviti provides an online tool for everyone to uncover COVID-19 concentrations by state and county level and find out the next hotspots. • What Rachel thinks the main trends in healthtech are and how they’re helping shape the “new normal”. no full 44 d2e516ec-8933-4bca-a92a-5660a97f2f3f How COVID-19 Is Helping Propel The At-Home Testing Market Into the Future Learn more about Alveo Technologies: www.alveotechnologies.com

]]> Sun, 30 Aug 2020 19:31:46 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Ron Chiarello) http://www.healthcareweekly.com Learn more about Alveo Technologies: www.alveotechnologies.com

]]> How COVID-19 Is Helping Propel The At-Home Testing Market Into the Future Codrin Arsene, Ron Chiarello 00:28:40 On today’s episode of the Healthcare Weekly Podcast, we are joined by Ron Chiarello from Alveo Technologies. Listen to Ron and learn about his exciting company which is closing the loop on at-home testing kits allowing patients to get near-instant test results. In the current at-home testing market, the usual process requires customers to take a blood sample and send it back to a lab for testing. Results are often available online within 3-5 business days after the lab receives the sample. Alveo Technologies plan to turn the market on its head with their proprietary test analyzer which can provide test results and actionable recommendations in approximately 30 minutes or less. Ron also talks about the first at-home coronavirus test his company is working on. Ease of use and low costs are the main considerations in creating the at-home COVID-19 test, which is currently in clinical trials. Listen to the podcast to learn about: • How being able to have affordable, easy access to at-home testing kits would impact the healthcare industry. • Why antibody testing, the most common at-home is not always the most reliable one • What to do with test results once you have them and the various options Alveo Technologies will provide to customers (telemedicine integration is one of them!). • Ron’s timeline for having the COVID test readily available to consumers • How America may return to a sense of normalcy and how effective testing could help with that goal. On today’s episode of the Healthcare Weekly Podcast, we are joined by Ron Chiarello from Alveo Technologies. Listen to Ron and learn about his exciting company which is closing the loop on at-home testing kits allowing patients to get near-instant test results. In the current at-home testing market, the usual process requires customers to take a blood sample and send it back to a lab for testing. Results are often available online within 3-5 business days after the lab receives the sample. Alveo Technologies plan to turn the market on its head with their proprietary test analyzer which can provide test results and actionable recommendations in approximately 30 minutes or less. Ron also talks about the first at-home coronavirus test his company is working on. Ease of use and low costs are the main considerations in creating the at-home COVID-19 test, which is currently in clinical trials. Listen to the podcast to learn about: • How being able to have affordable, easy access to at-home testing kits would impact the healthcare industry. • Why antibody testing, the most common at-home is not always the most reliable one • What to do with test results once you have them and the various options Alveo Technologies will provide to customers (telemedicine integration is one of them!). • Ron’s timeline for having the COVID test readily available to consumers • How America may return to a sense of normalcy and how effective testing could help with that goal. telemedicine, covid-19, covid-19 tests, at home tests no full 43 7fa55ae4-444b-4c23-8bc5-d518dc0fb73d AI in Life Sciences? Here's How That Works Learn more about Okra Technologies here: https://okra.ai

]]> Wed, 26 Aug 2020 20:22:27 +0000 codrin.arsene@digitalauthority.me (Loubna Bouarfa, codrin arsene) http://www.healthcareweekly.com Learn more about Okra Technologies here: https://okra.ai

]]> AI in Life Sciences? Here's How That Works Loubna Bouarfa, codrin arsene 00:25:58 Today’s guest is Dr. Loubna Bouarfa, CEO of Cambridge-based AI productization company OKRA Technologies. Founded in 2015, OKRA Technologies aims to create easily explainable and actionable data sets for healthcare workers. Utilizing the Okra Explainability Engine, the company empowers users by explaining the outputs behind AI systems. They offer solutions to existing teams in the Life Sciences industry to enable quick and decisive action to be taken by employees. Loubna joins us today to discuss how OKRA Technologies works to provide suggestions and awareness of emerging treatments, how they utilize historical data to prioritize needs and overcoming opposition to AI adoption. Listen to the podcast to learn about: • OKRA’S mission statement • How they select and serve their demographic • The process of articulating the correct treatments regardless of user location • Forecasting outcomes • How their engine provides suggestions and creates awareness of emerging treatments • Building trust and overcoming fear in the Life Sciences industry • Providing equal opportunities for everyone to have access to treatments • Drawing on historical data to prioritize needs for treatment • How OKRA provides insights • The effects of COVID-19 on the adoption of artificial intelligence • Creating explainable and accessible AI • The process of algorithm validation • Creating scalable solutions • What types and amount of data are needed to create operable algorithms? • The main challenges of adopting AI in the Life Sciences field • The build vs buy mentality and how it can be detrimental • Where Loubna sees the industry heading over the next decade Today’s guest is Dr. Loubna Bouarfa, CEO of Cambridge-based AI productization company OKRA Technologies. Founded in 2015, OKRA Technologies aims to create easily explainable and actionable data sets for healthcare workers. Utilizing the Okra Explainability Engine, the company empowers users by explaining the outputs behind AI systems. They offer solutions to existing teams in the Life Sciences industry to enable quick and decisive action to be taken by employees. Loubna joins us today to discuss how OKRA Technologies works to provide suggestions and awareness of emerging treatments, how they utilize historical data to prioritize needs and overcoming opposition to AI adoption. Listen to the podcast to learn about: • OKRA’S mission statement • How they select and serve their demographic • The process of articulating the correct treatments regardless of user location • Forecasting outcomes • How their engine provides suggestions and creates awareness of emerging treatments • Building trust and overcoming fear in the Life Sciences industry • Providing equal opportunities for everyone to have access to treatments • Drawing on historical data to prioritize needs for treatment • How OKRA provides insights • The effects of COVID-19 on the adoption of artificial intelligence • Creating explainable and accessible AI • The process of algorithm validation • Creating scalable solutions • What types and amount of data are needed to create operable algorithms? • The main challenges of adopting AI in the Life Sciences field • The build vs buy mentality and how it can be detrimental • Where Loubna sees the industry heading over the next decade covid-19, ai in pharma no full 42 45734456-9dc0-42a3-9501-e6b025a1ddf7 Can Medical Data Be Democratized? Learn more about Life Image by visiting: https://www.lifeimage.com

]]> Tue, 25 Aug 2020 22:21:13 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Life Image by visiting: https://www.lifeimage.com

]]> Can Medical Data Be Democratized? Codrin S Arsene 00:43:02 Today’s guest is Matt Michela, CEO of Life Image. Life Image is the world’s largest medical evidence and image exchange network, providing access to points of care and curated imaging data. Life Image was founded in 2008 and provides medical organizations and patients with centralized access to data via the use of their Interoperability Suite. The platform allows for seamless integration into existing EMR systems and offers a way to democratize data via a vendor-agnostic tool. Matt joins us today to discuss how their Interoperability Suite is utilized, the benefits of centralized data and the importance of contactless data collection during the pandemic. Listen to the podcast to learn about: • The type of data Life Image allows access to • Creating a data exchange for providers • How health systems access Life Image • Tailoring the platform to provider preference • Accelerating data access and decreasing stress • Creating seamless integrations into multiple health workflows • Utilizing embedded information in DICOM images • How Life Image helps outside partners with algorithm creation • Increasing the adoption rate of third-party partner tech • How Life Image is being utilized during COVID-19 • Trends emerging with providers during the pandemic • The importance of seamless data sharing with treatment centers • Decreasing infection chances by eliminating the need for physical data exchange Today’s guest is Matt Michela, CEO of Life Image. Life Image is the world’s largest medical evidence and image exchange network, providing access to points of care and curated imaging data. Life Image was founded in 2008 and provides medical organizations and patients with centralized access to data via the use of their Interoperability Suite. The platform allows for seamless integration into existing EMR systems and offers a way to democratize data via a vendor-agnostic tool. Matt joins us today to discuss how their Interoperability Suite is utilized, the benefits of centralized data and the importance of contactless data collection during the pandemic. Listen to the podcast to learn about: • The type of data Life Image allows access to • Creating a data exchange for providers • How health systems access Life Image • Tailoring the platform to provider preference • Accelerating data access and decreasing stress • Creating seamless integrations into multiple health workflows • Utilizing embedded information in DICOM images • How Life Image helps outside partners with algorithm creation • Increasing the adoption rate of third-party partner tech • How Life Image is being utilized during COVID-19 • Trends emerging with providers during the pandemic • The importance of seamless data sharing with treatment centers • Decreasing infection chances by eliminating the need for physical data exchange healthcare podcast, lifeimage, healthtech no full 41 99d205b7-26aa-4a24-90ec-40443f22a51b How Can Apps Help with Mindfulness Training? You can learn more about MindSciences and Dr. Jud Brewer by visiting: https://drjud.com/

]]> Sun, 16 Aug 2020 15:37:52 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com You can learn more about MindSciences and Dr. Jud Brewer by visiting: https://drjud.com/

]]> How Can Apps Help with Mindfulness Training? Codrin S Arsene 00:40:45 Today’s guest is Dr. Jud Brewer, Director of Research and Innovation, Mindfulness Center at Brown University and senior scientific and medical advisor for behavioral health at Sharecare and the creator of MindSciences. Reminiscing on how MindSciences began at Yale, Dr. Brewer takes us back to 2012 when smartphones started becoming more prevalent. The good doctor tells us about how he aspired to develop digital-based therapeutics and how he spent almost one decade achieving this mission. MindSciences is currently the leading evidence-based behavior change app and it has recently been acquired by Sharecare. Dr. Brewer explains what neurofeedback is and how Anderson Cooper became involved with it for a story on 60 Minutes. Focusing on smoking habits, Dr. Brewer breaks down the two main components of cravings, both physiological and psychological, and the roles those play in our habits - and how digital-enabled platforms can help smokers quit. Listen to the podcast further to learn about: • How your habit can be influenced by algorithms & daily regiments • How mental awareness can help you • How COVID-19 and quarantine are affecting habits in general • How an app can make sure you achieve your health goals and alter behavior • Discover what mindfulness training is and how it can benefit you • The importance and significance of digital outreach • The future plans for MindSciences after being acquired by Sharecare Today’s guest is Dr. Jud Brewer, Director of Research and Innovation, Mindfulness Center at Brown University and senior scientific and medical advisor for behavioral health at Sharecare and the creator of MindSciences. Reminiscing on how MindSciences began at Yale, Dr. Brewer takes us back to 2012 when smartphones started becoming more prevalent. The good doctor tells us about how he aspired to develop digital-based therapeutics and how he spent almost one decade achieving this mission. MindSciences is currently the leading evidence-based behavior change app and it has recently been acquired by Sharecare. Dr. Brewer explains what neurofeedback is and how Anderson Cooper became involved with it for a story on 60 Minutes. Focusing on smoking habits, Dr. Brewer breaks down the two main components of cravings, both physiological and psychological, and the roles those play in our habits - and how digital-enabled platforms can help smokers quit. Listen to the podcast further to learn about: • How your habit can be influenced by algorithms & daily regiments • How mental awareness can help you • How COVID-19 and quarantine are affecting habits in general • How an app can make sure you achieve your health goals and alter behavior • Discover what mindfulness training is and how it can benefit you • The importance and significance of digital outreach • The future plans for MindSciences after being acquired by Sharecare no full 40 38b8a6f2-5ed3-4122-b40c-c3d73256b2f5 Unifying Health Care and Community Learn more about Unite Us by visiting: https://uniteus.com

]]> Tue, 4 Aug 2020 23:32:28 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Unite Us by visiting: https://uniteus.com

]]> Unifying Health Care and Community Codrin S Arsene 00:37:19 Today’s guest is Dan Brillman, co-founder and CEO of Unite Us. Dan is a Yale graduate who, after starting a career in finance, joined the Air Force Reserves as a pilot. After several combat deployments, Dan realized the transition for veterans back into the civilian life was not as seamless as it should be. This inspired him to create a solution. Unite Us is a platform that acts as a unifying infrastructure between health care entities and community-based organizations. By utilizing electronic referral services, Unite Us aims to improve access to services for groups that need it most. Dan joins us today to discuss the functionality of the Unite Us platform, who benefits most from its resources and how the data collected can be analyzed for systemic improvements. Listen to the podcast to learn about: • The health care access problems for veterans • How Unite Us improves coordination of supply chains and service navigation • Why the initial model of the company didn’t work for the business or users • How Unite Us presented a solution for statewide coordinative care in North Carolina • The impact of COVID-19: Accelerating the launch of the platform • Providing insight to government by utilizing data regarding efficiency, demand and supply • What other vulnerable groups can benefit from the platform • The extent of accessible services on Unite Us • Predicting social needs and risk factors using aggregate data • Creating actionable data to move the industry forward • Legislative barriers to expansion • The necessity to focus on what is right for the patient across the industry • Emerging tech trends that could propel the business Today’s guest is Dan Brillman, co-founder and CEO of Unite Us. Dan is a Yale graduate who, after starting a career in finance, joined the Air Force Reserves as a pilot. After several combat deployments, Dan realized the transition for veterans back into the civilian life was not as seamless as it should be. This inspired him to create a solution. Unite Us is a platform that acts as a unifying infrastructure between health care entities and community-based organizations. By utilizing electronic referral services, Unite Us aims to improve access to services for groups that need it most. Dan joins us today to discuss the functionality of the Unite Us platform, who benefits most from its resources and how the data collected can be analyzed for systemic improvements. Listen to the podcast to learn about: • The health care access problems for veterans • How Unite Us improves coordination of supply chains and service navigation • Why the initial model of the company didn’t work for the business or users • How Unite Us presented a solution for statewide coordinative care in North Carolina • The impact of COVID-19: Accelerating the launch of the platform • Providing insight to government by utilizing data regarding efficiency, demand and supply • What other vulnerable groups can benefit from the platform • The extent of accessible services on Unite Us • Predicting social needs and risk factors using aggregate data • Creating actionable data to move the industry forward • Legislative barriers to expansion • The necessity to focus on what is right for the patient across the industry • Emerging tech trends that could propel the business no full 39 34b26f0e-0296-41ca-8451-d10ecee67b52 Are Stem Cells the Answer to COVID-19 long term damage to the human body? Learn more about GIOSTAR by visiting: https://www.giostar.com

]]> Sat, 11 Jul 2020 01:37:10 +0000 codrin.arsene@digitalauthority.me (Anand Srivastava, Codrin Arsene) http://www.healthcareweekly.com Learn more about GIOSTAR by visiting: https://www.giostar.com

]]> Are Stem Cells the Answer to COVID-19 long term damage to the human body? Anand Srivastava, Codrin Arsene 00:38:22 Today’s guest is Dr. Anand Srivastava. He is the Co-founder, Chairman and Chief Scientific Officer of GIOSTAR. GIOSTAR is the Global Institute of Stem Cell Therapy and Research. Under Dr. Anand’s leadership, scientists and clinicians have developed and established stem cell therapies for various types of autoimmune diseases and blood disorders. Dr. Anand joins us today to discuss his experience in the field of stem cell research, the uses for stem cells and how they could be employed to battle COVID-19. Listen to the podcast to learn about: Public vs. government perspectives on stem cell research The history of stem cell research The modern approach to stem cell therapy: regenerative medicine Understanding the spectrum of diseases humans are prone to How stem cells can be applied to help with metabolic malfunction Regenerative medicine to battle degenerative disease How the connotations of ‘embryonic’ impacted perceptions The multi-national effort to research stem cell applications to battle COVID-19 The importance of understanding the physiology of the COVID-19 virus Why people with underlying conditions and the elderly are more affected by COVID-19 How the coronavirus could impact perceptions of stem cell research The continuing necessity of a vaccine Why we need a multiple approach strategy to tackle COVID-19 Potential issues meeting supply and demand of stem cells in the future What the future of the industry holds Today’s guest is Dr. Anand Srivastava. He is the Co-founder, Chairman and Chief Scientific Officer of GIOSTAR. GIOSTAR is the Global Institute of Stem Cell Therapy and Research. Under Dr. Anand’s leadership, scientists and clinicians have developed and established stem cell therapies for various types of autoimmune diseases and blood disorders. Dr. Anand joins us today to discuss his experience in the field of stem cell research, the uses for stem cells and how they could be employed to battle COVID-19. Listen to the podcast to learn about: Public vs. government perspectives on stem cell research The history of stem cell research The modern approach to stem cell therapy: regenerative medicine Understanding the spectrum of diseases humans are prone to How stem cells can be applied to help with metabolic malfunction Regenerative medicine to battle degenerative disease How the connotations of ‘embryonic’ impacted perceptions The multi-national effort to research stem cell applications to battle COVID-19 The importance of understanding the physiology of the COVID-19 virus Why people with underlying conditions and the elderly are more affected by COVID-19 How the coronavirus could impact perceptions of stem cell research The continuing necessity of a vaccine Why we need a multiple approach strategy to tackle COVID-19 Potential issues meeting supply and demand of stem cells in the future What the future of the industry holds stem cells, covid-19, covid19 no full 37 15769694-8d81-4e8d-a79e-3de2fae4c7b7 Can AI help help improve the quality of care for the elderly? One startup is betting on it. Learn more about Dina by visiting: https://www.dinacare.com

]]> Fri, 10 Jul 2020 00:29:32 +0000 codrin.arsene@digitalauthority.me (Ashish Shah, Codrin Arsene) http://www.healthcareweekly.com Learn more about Dina by visiting: https://www.dinacare.com

]]> Can AI help help improve the quality of care for the elderly? One startup is betting on it. Ashish Shah, Codrin Arsene 00:43:07 Today’s guest is Ashish Shah, Co-Founder and CEO of Dina. Dina is an AI-powered care coordination platform aimed to help the elderly population that live at home independently on their own terms. Dina organizes different ways to access care options in the community, such as nutrition and medical equipment needs, allowing for greater individual autonomy. With Dina, Ashish hopes to be able to educate home caregivers and individuals about what is available in their community while reducing the need for institutionalized care. Ashish joins us to discuss how Dina works, who can benefit from this innovative solution and how the COVID-19 pandemic has influenced the priorities his team is working on Listen to the podcast to learn about: • The kind of decisions the elderly population face • How Dina platform works & what it’s designed to do • What gaps exist currently in the at-home service industry for the 65+ population • How Dina can be used to track an individual’s health status • Technology trends of the future impacting the healthcare industry • The type of AI services Dina employs • How the COVID-19 outbreak is accelerating innovation in the healthcare space • Large companies vs. small companies’ approach to innovation in healthcare • COVID-19 and the positive impact on long-term healthcare solutions Today’s guest is Ashish Shah, Co-Founder and CEO of Dina. Dina is an AI-powered care coordination platform aimed to help the elderly population that live at home independently on their own terms. Dina organizes different ways to access care options in the community, such as nutrition and medical equipment needs, allowing for greater individual autonomy. With Dina, Ashish hopes to be able to educate home caregivers and individuals about what is available in their community while reducing the need for institutionalized care. Ashish joins us to discuss how Dina works, who can benefit from this innovative solution and how the COVID-19 pandemic has influenced the priorities his team is working on Listen to the podcast to learn about: • The kind of decisions the elderly population face • How Dina platform works & what it’s designed to do • What gaps exist currently in the at-home service industry for the 65+ population • How Dina can be used to track an individual’s health status • Technology trends of the future impacting the healthcare industry • The type of AI services Dina employs • How the COVID-19 outbreak is accelerating innovation in the healthcare space • Large companies vs. small companies’ approach to innovation in healthcare • COVID-19 and the positive impact on long-term healthcare solutions elderly, elderly care, dina health no full 35 a7a53398-a4eb-43f8-8e69-97fedbc36f76 Getting Venture Capital in Healthcare: Everything You Need to Know Learn more about GSR Ventures by visiting: http://www.gsrventures.com/en

]]> Wed, 24 Jun 2020 01:24:44 +0000 codrin.arsene@digitalauthority.me (Richard Lim, Codrin Arsene) http://www.healthcareweekly.com Learn more about GSR Ventures by visiting: http://www.gsrventures.com/en

]]> Getting Venture Capital in Healthcare: Everything You Need to Know Richard Lim, Codrin Arsene 01:02:44 Getting Venture Capital in Healthcare: Everything You Need to Know Today’s podcast guest is Richard Lim. Richard is co-founder and Managing Director of GSR Ventures. His company is a global investment firm with $3 billion under management and consists of independently managed funds in China, Singapore, and the US. GSR Ventures invests in early stage technology companies across the globe helping transformative companies change the healthcare ecosystem with their innovations. Richard joins us today to discuss AI adoption in the medical field, the impact of COVID-19 on healthcare and the stages of securing funding for entrepreneurs. Listen to the podcast to learn about: • The difficulty of convincing medical professionals to adopt technology • How COVID-19 has led to an increase in telemedicine adoption • The potential impacts of Artificial Intelligence on healthcare • Combining traditional tech and AI in the healthcare industry • The types of healthcare companies likely to be funded during the pandemic • The important role AI systems play in Radiology (also covered here, here and here) • The difference between the US and China when it comes to adopting AI solutions • Using AI systems in pharmaceuticals to drive new treatments • When to seek funding as an entrepreneur • The extent to which AI could automate physician workload Getting Venture Capital in Healthcare: Everything You Need to Know Today’s podcast guest is Richard Lim. Richard is co-founder and Managing Director of GSR Ventures. His company is a global investment firm with $3 billion under management and consists of independently managed funds in China, Singapore, and the US. GSR Ventures invests in early stage technology companies across the globe helping transformative companies change the healthcare ecosystem with their innovations. Richard joins us today to discuss AI adoption in the medical field, the impact of COVID-19 on healthcare and the stages of securing funding for entrepreneurs. Listen to the podcast to learn about: • The difficulty of convincing medical professionals to adopt technology • How COVID-19 has led to an increase in telemedicine adoption • The potential impacts of Artificial Intelligence on healthcare • Combining traditional tech and AI in the healthcare industry • The types of healthcare companies likely to be funded during the pandemic • The important role AI systems play in Radiology (also covered here, here and here) • The difference between the US and China when it comes to adopting AI solutions • Using AI systems in pharmaceuticals to drive new treatments • When to seek funding as an entrepreneur • The extent to which AI could automate physician workload early stage funding, artificial intelligence in healthcare no full 38 b3ed890d-7802-470d-b5b7-62d637cb4618 [Podcast]: Drones for good: how one company uses drone technology to deliver vaccines & medical supplies Learn more about Swoop Aero by visiting: https://swoop.aero

]]> Mon, 15 Jun 2020 21:10:06 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Swoop Aero by visiting: https://swoop.aero

]]> [Podcast]: Drones for good: how one company uses drone technology to deliver vaccines & medical supplies Codrin S Arsene 00:43:59 Today’s guest is Eric Peck, co-founder and CEO of Swoop Aero. Swoop Aero is an Australian-based medical supply logistics company that utilizes drones to deliver critical medical supplies to doctors and patients in need across the world. In addition to Australia, they also operate in Malawi and Mozambique to deliver high value, in-demand medical supplies cutting down delivery time and costs associated with moving medical supplies from point A to point B. With Swoop Aero, Eric hopes to increase the accessibility of medical supplies in communities across the globe while improving efficiency and speed of deliveries. Eric joins us today to discuss his air force background, the inspiration behind Swoop Aero, along with common questions and challenges they face. Listen to the podcast to learn about: • Swoop Aero’s end-user technology vs. operations technology • Future scalability and ease of implementation • Proactively battling hacking and security concerns • How Swoop Aero compares to other emerging drone deliver services • The impact of COVID-19 on delivery dockets • The future of combining autonomous and traditional logistics channels • Swoop Aero’s client base • Overcoming the challenges of operating in perceived high-risk countries • Environmental and operational risk factors • Long term differentiators between Swoop Aero and competitors Today’s guest is Eric Peck, co-founder and CEO of Swoop Aero. Swoop Aero is an Australian-based medical supply logistics company that utilizes drones to deliver critical medical supplies to doctors and patients in need across the world. In addition to Australia, they also operate in Malawi and Mozambique to deliver high value, in-demand medical supplies cutting down delivery time and costs associated with moving medical supplies from point A to point B. With Swoop Aero, Eric hopes to increase the accessibility of medical supplies in communities across the globe while improving efficiency and speed of deliveries. Eric joins us today to discuss his air force background, the inspiration behind Swoop Aero, along with common questions and challenges they face. Listen to the podcast to learn about: • Swoop Aero’s end-user technology vs. operations technology • Future scalability and ease of implementation • Proactively battling hacking and security concerns • How Swoop Aero compares to other emerging drone deliver services • The impact of COVID-19 on delivery dockets • The future of combining autonomous and traditional logistics channels • Swoop Aero’s client base • Overcoming the challenges of operating in perceived high-risk countries • Environmental and operational risk factors • Long term differentiators between Swoop Aero and competitors no full 36 0d103761-93dc-4d19-b499-bce5c6818935 How Artificial Intelligence Will Change Healthcare Learn more about Pactera EDGE here: https://www.pacteraedge.com

]]> Wed, 10 Jun 2020 21:32:44 +0000 codrin.arsene@digitalauthority.me (Ahmer Inam, Codrin Arsene) http://www.healthcareweekly.com Learn more about Pactera EDGE here: https://www.pacteraedge.com

]]> How Artificial Intelligence Will Change Healthcare Ahmer Inam, Codrin Arsene 00:49:09 Today’s guest is Ahmer Inam. Ahmer serves as Chief AI Officer at Pactera EDGE and has a background working with industry leaders in his field of AI and predictive analytics. Ahmer has worked previously for the International Institute of Analytics, Cambria Health Solutions and NIKE. As an excellent AI generalist, Ahmer joins us today to discuss various use cases on how artificial intelligence can improve the delivery of care in the healthcare industry. He also includes some thoughts on how AI can help with logistics during the COVID-19 pandemic. Listen to the podcast to learn about: • What artificial intelligence is • How AI can apply to the healthcare industry • Automation and the importance of data sharing • Unsupervised learning models • Supervised learning models • Reinforced learning models • Solving logistics and supply chain issues during a pandemic with AI • Data bias: What causes it and how to prevent it • How fear of new technology prevents mass adoption • The human element of AI • Taking calculated risks with AI adoption Today’s guest is Ahmer Inam. Ahmer serves as Chief AI Officer at Pactera EDGE and has a background working with industry leaders in his field of AI and predictive analytics. Ahmer has worked previously for the International Institute of Analytics, Cambria Health Solutions and NIKE. As an excellent AI generalist, Ahmer joins us today to discuss various use cases on how artificial intelligence can improve the delivery of care in the healthcare industry. He also includes some thoughts on how AI can help with logistics during the COVID-19 pandemic. Listen to the podcast to learn about: • What artificial intelligence is • How AI can apply to the healthcare industry • Automation and the importance of data sharing • Unsupervised learning models • Supervised learning models • Reinforced learning models • Solving logistics and supply chain issues during a pandemic with AI • Data bias: What causes it and how to prevent it • How fear of new technology prevents mass adoption • The human element of AI • Taking calculated risks with AI adoption ahmer inam, healthcare podcast, ai in healthcare, codrin arsene no full 34 91c75632-4ee4-4207-9fc4-455b537fea89 How Traction Thrive Helps Healthcare Workers Fighting COVID-19 Learn more about Traction on Demand by visiting https://tractionondemand.com/

]]> Tue, 26 May 2020 16:35:58 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Traction on Demand by visiting https://tractionondemand.com/

]]> How Traction Thrive Helps Healthcare Workers Fighting COVID-19 Codrin S Arsene 00:28:14 In this episode we welcome Greg Malpass, CEO of Traction on Demand. His company has launched a free, open-source mobile application for healthcare providers that are fighting the COVID-19 outbreak. The app is called Traction Thrive and helps to manage healthcare equipment during the pandemic. Traction Thrive is a new initiative which came about as a reaction to the ongoing epidemic, so Greg takes us through his thought process on why this app was prioritized and built over any other ideas. He explains the user experience and typical workflows for healthcare workers and how different resources can be assigned based on a supply and demand algorithm via this new and innovative software. Traction Thrive is available only in Canada right now, but Greg explains that his company is working hard to make it available in the United States and other countries. In addition to this timely app, Greg also talks about other useful tools created by Traction on Demand. Codrin and Greg later share their thoughts on how healthcare might be changed forever because of COVID-19. Listen to the podcast to learn about: • How Traction on Demand decided to built and launch Traction Thrive • The experience that a hospital worker has when using the app. • The growth trajectory that Traction Thrive has already experienced. • How data is leveraged in healthcare to make better decisions. • Other service offerings / products built by Traction on Demand. • Why we need progressive solutions now more than ever in healthcare and beyond. • How companies are forced to innovate during COVID-19 Learn more about the company by visiting: www.tractionondemand.com In this episode we welcome Greg Malpass, CEO of Traction on Demand. His company has launched a free, open-source mobile application for healthcare providers that are fighting the COVID-19 outbreak. The app is called Traction Thrive and helps to manage healthcare equipment during the pandemic. Traction Thrive is a new initiative which came about as a reaction to the ongoing epidemic, so Greg takes us through his thought process on why this app was prioritized and built over any other ideas. He explains the user experience and typical workflows for healthcare workers and how different resources can be assigned based on a supply and demand algorithm via this new and innovative software. Traction Thrive is available only in Canada right now, but Greg explains that his company is working hard to make it available in the United States and other countries. In addition to this timely app, Greg also talks about other useful tools created by Traction on Demand. Codrin and Greg later share their thoughts on how healthcare might be changed forever because of COVID-19. Listen to the podcast to learn about: • How Traction on Demand decided to built and launch Traction Thrive • The experience that a hospital worker has when using the app. • The growth trajectory that Traction Thrive has already experienced. • How data is leveraged in healthcare to make better decisions. • Other service offerings / products built by Traction on Demand. • Why we need progressive solutions now more than ever in healthcare and beyond. • How companies are forced to innovate during COVID-19 Learn more about the company by visiting: www.tractionondemand.com no full 31 10452c66-56f0-4ff3-a242-e1f5a24323be Is Updox the COVID-19 Healthcare Solution Consumers Are Looking For? Learn more about Updox by visiting https://www.updox.com/

]]> Tue, 5 May 2020 05:00:58 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Michael Morgan) http://www.healthcareweekly.com Learn more about Updox by visiting https://www.updox.com/

]]> Is Updox the COVID-19 Healthcare Solution Consumers Are Looking For? Codrin Arsene, Michael Morgan 00:28:45 Michael Morgan is Healthcare Weekly’s podcast guest of the day. He is the CEO of Updox, a health tech collaboration platform that offers appointment reminders, secure texting and messaging, e-faxing, live video interoffice chatting, and a recently announced telehealth platform that can be used by doctors and physicians all over the country. Updox allows health professionals to communicate more efficiently with both practicing colleagues and patients. The company offers integrated solutions where health care providers can use one collaborative platform instead of multiple, disjointed communication channels. Recently, Updox partnered with ShareCare (check our podcast episode with ShareCare’s CEO here) since they share a common vision. Updox can help health organizations save time and money and even increase their profits. Topics Covered on today’s podcast: • The all-in-one platform offered by Updox • Their new partnership with ShareCare • How Updox’s telemedicine solution is different from other alternatives available on the market today • How COVID-19 restrictions are encouraging businesses to adopt remote monitoring solutions • The benefits gained by medical practitioners when they use Updox • The biggest trends emerging from dealing with COVID-19 among healthcare professionals Michael Morgan is Healthcare Weekly’s podcast guest of the day. He is the CEO of Updox, a health tech collaboration platform that offers appointment reminders, secure texting and messaging, e-faxing, live video interoffice chatting, and a recently announced telehealth platform that can be used by doctors and physicians all over the country. Updox allows health professionals to communicate more efficiently with both practicing colleagues and patients. The company offers integrated solutions where health care providers can use one collaborative platform instead of multiple, disjointed communication channels. Recently, Updox partnered with ShareCare (check our podcast episode with ShareCare’s CEO here) since they share a common vision. Updox can help health organizations save time and money and even increase their profits. Topics Covered on today’s podcast: • The all-in-one platform offered by Updox • Their new partnership with ShareCare • How Updox’s telemedicine solution is different from other alternatives available on the market today • How COVID-19 restrictions are encouraging businesses to adopt remote monitoring solutions • The benefits gained by medical practitioners when they use Updox • The biggest trends emerging from dealing with COVID-19 among healthcare professionals telemedicine, healthtech, healthcare collaboration platforms no full 33 fad573f2-c3ad-4a87-8f78-1e1f6542e0ad Why America's original response to coronavirus was a total disaster (guest Dr. Rishi Desai) Learn more about Osmosis by visiting: https://www.osmosis.org/

]]> Sat, 25 Apr 2020 19:13:11 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Rishi Desai) http://www.healthcareweekly.com Learn more about Osmosis by visiting: https://www.osmosis.org/

]]> Why America's original response to coronavirus was a total disaster (guest Dr. Rishi Desai) Codrin Arsene, Rishi Desai 00:41:45 America’s original response to the coronavirus was a total disaster. In January and February, no one thought twice of this epidemic - at least, no one in a position to actually do something meaningful about it. With so much fake news floating around, from both sides of the aisle, it’s really difficult to figure out what’s real and what’s speculation. Today’s guest is Dr. Rishi Desai, Chief Medical Officer of Osmosis. Dr. Desai joins us today to discuss the COVID-19 pandemic, how the response to the disease has impacted the scale of the outbreak and answers questions regarding testing, the CDC and what to expect moving forward. He shares his extremely valuable insights to help us understand what has gone wrong in terms of America’s approach to the novel coronavirus. Listen to the podcast to learn about: • What could have been done differently in response to COVID-19 • The reason for testing delays and shortages in the United States • The response of the CDC • Progression of the treatment protocols • The strains placed on the healthcare system due to poor planning • The validity and safety of anti-viral treatments in the context of COVID-19 • Reasons for the continued case increases • Why the United States has struggled more than other countries • Possible projections for the course of the disease • How pre-existing conditions have had an impact on case numbers More info: About the guest: Dr. Desai has a background in public health, has worked as a pediatric epidemiologist, and has also served as an epidemic intelligence service officer for the CDC. He has investigated emerging pandemics in America (and the entire world) and was also part of the Division of Viral Diseases within the CDC. About the company he works for: Osmosis is a learning platform for clinicians, medical students and caregivers alike. Osmosis believes learning should be simple, enjoyable and efficient and offers many different tools to help you achieve your learning goals such as video, mobile platforms and high-yield notes. America’s original response to the coronavirus was a total disaster. In January and February, no one thought twice of this epidemic - at least, no one in a position to actually do something meaningful about it. With so much fake news floating around, from both sides of the aisle, it’s really difficult to figure out what’s real and what’s speculation. Today’s guest is Dr. Rishi Desai, Chief Medical Officer of Osmosis. Dr. Desai joins us today to discuss the COVID-19 pandemic, how the response to the disease has impacted the scale of the outbreak and answers questions regarding testing, the CDC and what to expect moving forward. He shares his extremely valuable insights to help us understand what has gone wrong in terms of America’s approach to the novel coronavirus. Listen to the podcast to learn about: • What could have been done differently in response to COVID-19 • The reason for testing delays and shortages in the United States • The response of the CDC • Progression of the treatment protocols • The strains placed on the healthcare system due to poor planning • The validity and safety of anti-viral treatments in the context of COVID-19 • Reasons for the continued case increases • Why the United States has struggled more than other countries • Possible projections for the course of the disease • How pre-existing conditions have had an impact on case numbers More info: About the guest: Dr. Desai has a background in public health, has worked as a pediatric epidemiologist, and has also served as an epidemic intelligence service officer for the CDC. He has investigated emerging pandemics in America (and the entire world) and was also part of the Division of Viral Diseases within the CDC. About the company he works for: Osmosis is a learning platform for clinicians, medical students and caregivers alike. Osmosis believes learning should be simple, enjoyable and efficient and offers many different tools to help you achieve your learning goals such as video, mobile platforms and high-yield notes. coronavirus no full 32 08795dc7-e753-4731-80aa-1b08e3d9df68 Fireside chat with WebMD & Sharecare Founder Jeff Arnold on Covid-19 & The Future of Medicine. Learn more about Sharecare by visiting https://www.sharecare.com/ 

]]> Mon, 20 Apr 2020 23:09:33 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Sharecare by visiting https://www.sharecare.com/ 

]]> Fireside chat with WebMD & Sharecare Founder Jeff Arnold on Covid-19 & The Future of Medicine. Codrin S Arsene 00:52:33 Today’s guest on Healthcare Weekly is Jeff Arnold. He founded WebMD in 1998 and is now the CEO of Sharecare, a digital health company. Sharecare provides personalized content to help people manage their health, adjust their behavior, and improve their overall health. When Jeff started WebMD, only 26% of Americans had internet access. Since then, the number has increased to 90%, thus making content consumption much more accessible and opening up so many healthcare opportunities. Jeff explains how artificial intelligence can and will play a critical role in the delivery of healthcare services in the United states, as it can be used to organize patient data, go through lists of information, learn from phone conversations, and so on. However, its role is only supportive to doctors and will never be able to replace them. Topics covered: • Establishing trust in content • Distinguishing between fake and real news in the age of Covid-19 • The impact of COVID-19 on how we perceive content and data, plus Sharecare’s Real Age Test • The fear of COVID-19 case numbers increasing again when restrictions are lifted and the solutions deployed by Sharecare to help mitigate a new wave of infections. • How employers can get insights from health data and act on it to keep work environments safe and secure • The future of the integrated consumer path between informational content and clinical decision making • Predictions of the future of healthcare, Artificial Intelligence, and the myth of giving up on doctors Today’s guest on Healthcare Weekly is Jeff Arnold. He founded WebMD in 1998 and is now the CEO of Sharecare, a digital health company. Sharecare provides personalized content to help people manage their health, adjust their behavior, and improve their overall health. When Jeff started WebMD, only 26% of Americans had internet access. Since then, the number has increased to 90%, thus making content consumption much more accessible and opening up so many healthcare opportunities. Jeff explains how artificial intelligence can and will play a critical role in the delivery of healthcare services in the United states, as it can be used to organize patient data, go through lists of information, learn from phone conversations, and so on. However, its role is only supportive to doctors and will never be able to replace them. Topics covered: • Establishing trust in content • Distinguishing between fake and real news in the age of Covid-19 • The impact of COVID-19 on how we perceive content and data, plus Sharecare’s Real Age Test • The fear of COVID-19 case numbers increasing again when restrictions are lifted and the solutions deployed by Sharecare to help mitigate a new wave of infections. • How employers can get insights from health data and act on it to keep work environments safe and secure • The future of the integrated consumer path between informational content and clinical decision making • Predictions of the future of healthcare, Artificial Intelligence, and the myth of giving up on doctors no full 30 fd9e3ee3-49dd-4807-9228-4a36217bd8eb Let's talk about healthcare benefits brokers in America Learn more about Health Rosetta by visiting https://healthrosetta.org/

]]> Thu, 16 Apr 2020 00:48:02 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Health Rosetta by visiting https://healthrosetta.org/

]]> Let's talk about healthcare benefits brokers in America Codrin S Arsene 00:31:59 On today’s episode, our guest is Dave Chase, Cofounder and Creator of Health Rosetta. His company provides a blueprint to benefit brokers and managers on how to spend less on employee health benefits while still providing better outcomes for these employees. In theory, self-insured employers should be saving a portion of their normal expenses on health care, but their carriers are preventing that from happening via price gouging and surprise bills. Health Rosetta started working as a non-profit by teaching ways to spend less on health care and through professional accreditations. They have also set up a public benefit court to be able to achieve further heights. A lot of us don’t know the full dynamics of our health care payments, but Dave explains that once we start learning, we’ll be able to save more by getting rid of all the useless liabilities. Topics covered: • The way health benefits work in the U.S. from the top of the pyramid to the bottom • The power of insurance companies and pharmacies on the largest health benefit managements • Increasing health care costs on employers and employees due to the opaque ways adopted by insurance plans • Self-insured employers • The ways through which Health Rosetta can tackle the highlighted issues and benefit employers • The differences that make Dave’s approach better than the current establishment • The role of doctors in the current crisis • Savings and reductions which Health Rosetta would contribute • Using a technology platform to help benefit managers configure their health care plans On today’s episode, our guest is Dave Chase, Cofounder and Creator of Health Rosetta. His company provides a blueprint to benefit brokers and managers on how to spend less on employee health benefits while still providing better outcomes for these employees. In theory, self-insured employers should be saving a portion of their normal expenses on health care, but their carriers are preventing that from happening via price gouging and surprise bills. Health Rosetta started working as a non-profit by teaching ways to spend less on health care and through professional accreditations. They have also set up a public benefit court to be able to achieve further heights. A lot of us don’t know the full dynamics of our health care payments, but Dave explains that once we start learning, we’ll be able to save more by getting rid of all the useless liabilities. Topics covered: • The way health benefits work in the U.S. from the top of the pyramid to the bottom • The power of insurance companies and pharmacies on the largest health benefit managements • Increasing health care costs on employers and employees due to the opaque ways adopted by insurance plans • Self-insured employers • The ways through which Health Rosetta can tackle the highlighted issues and benefit employers • The differences that make Dave’s approach better than the current establishment • The role of doctors in the current crisis • Savings and reductions which Health Rosetta would contribute • Using a technology platform to help benefit managers configure their health care plans no full 28 ef899042-0d8d-404d-ad93-ed5432429654 Democratizing consumer healthcare access with HealthChampion Learn more about HealthChampion by visiting https://myhealthchampion.com/

]]> Mon, 13 Apr 2020 19:06:09 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about HealthChampion by visiting https://myhealthchampion.com/

]]> Democratizing consumer healthcare access with HealthChampion Codrin S Arsene 00:58:46 Today’s guest is Terrance Ryan, CEO of HealthChampion, a digital health analytics company focused on returning us to a people-driven healthcare ecosystem. HealthChampion is focused on digitizing and analyzing healthcare, empowering consumers to have greater control over their health data and decisions. HealthChampion works like a digital health passport. They currently offer their app for free, with a goal of rolling out a premium edition in the future. Many individuals have multiple health-related apps on their phones, as well as other health-related devices such as smart watches, fitness trackers, and even scales. These apps and devices are part of their daily lives. HealthChampion allows the consumer to consolidate information from all these areas, as well as electronic healthcare records. Over 400 apps and devices are compatible with HealthChampion, with more being added daily. Using the app, consumers will not only be able to consolidate and learn from their data, but share it in any way they need. This could include sharing health information with a spouse or doctor. HealthChampion is HIPA compliant, and it is up to the consumer to choose what information they want to share and with whom. Listen to the podcast to learn about: • How HealthChampion works in an end consumer point of view • Authentication protocols • How your data is shared with doctors and hospitals • How integration works within the app • Future goals for content uploading • How HealthChampion is planning to help with COVID-19 • Pathways of COVID-19 symptom tracker • What can be seen on your HealthChampion profile • Benefits of freely flowing information • Device compatibility with HealthChampion • Consumer benefits from being able to access your health information online in one place • The biggest challenges faced by HealthChampion right now Today’s guest is Terrance Ryan, CEO of HealthChampion, a digital health analytics company focused on returning us to a people-driven healthcare ecosystem. HealthChampion is focused on digitizing and analyzing healthcare, empowering consumers to have greater control over their health data and decisions. HealthChampion works like a digital health passport. They currently offer their app for free, with a goal of rolling out a premium edition in the future. Many individuals have multiple health-related apps on their phones, as well as other health-related devices such as smart watches, fitness trackers, and even scales. These apps and devices are part of their daily lives. HealthChampion allows the consumer to consolidate information from all these areas, as well as electronic healthcare records. Over 400 apps and devices are compatible with HealthChampion, with more being added daily. Using the app, consumers will not only be able to consolidate and learn from their data, but share it in any way they need. This could include sharing health information with a spouse or doctor. HealthChampion is HIPA compliant, and it is up to the consumer to choose what information they want to share and with whom. Listen to the podcast to learn about: • How HealthChampion works in an end consumer point of view • Authentication protocols • How your data is shared with doctors and hospitals • How integration works within the app • Future goals for content uploading • How HealthChampion is planning to help with COVID-19 • Pathways of COVID-19 symptom tracker • What can be seen on your HealthChampion profile • Benefits of freely flowing information • Device compatibility with HealthChampion • Consumer benefits from being able to access your health information online in one place • The biggest challenges faced by HealthChampion right now no full 27 dc583a82-dc3f-414a-9169-b318f9421ec3 Screening for COVID-19 with Rimidi Learn more about Rimidi by visiting https://rimidi.com/ and https://healthcare.rimidi.com/covid19

]]> Mon, 6 Apr 2020 17:10:02 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Rimidi by visiting https://rimidi.com/ and https://healthcare.rimidi.com/covid19

]]> Screening for COVID-19 with Rimidi Codrin S Arsene 00:17:23 Today’s guest is Dr. Lucienne Ide. She is the founder of Rimidi, a digital healthcare company that provides cloud-based software and clinical analytics for chronic disease management. Rimidi is now offering a new application to help support clinics during the new COVID-19 outbreak. The app works to screen patients for symptoms or risk factors before they come into the healthcare system. With this enhanced pre-screening, clinics can identify at-risk patients earlier in the process and take the necessary precautions to properly deal with the situation. Rimidi is working closely with the CDC to ensure the accuracy of questions at a time when information on the virus is changing daily. Survey questions are no longer just for those who have travelled internationally, but for everyone experiencing symptoms as there have now been cases of community spread. The app now works off information regarding symptoms, exposure risk, and travel to identify those who may be at risk. Rimidi is working to keep their COVID-19 survey as short and simple as possible. Individuals with an appointment will get a text reminding them of their appointment and a link to complete the survey. The survey is web-based to ensure it will function on all devices. If the individual is considered to be at risk, they will be given a number to contact on the next actions they should take. Listen to the podcast to learn about: Where Rimidi is being rolled out Identifying and dealing with patients who may have COVID-19 Things that have changed in screening as we learn more about the virus How the app works to identify at-risk individuals The user experience with Rimidi Survey questions that Rimidi uses to identify COVID-19 Today’s guest is Dr. Lucienne Ide. She is the founder of Rimidi, a digital healthcare company that provides cloud-based software and clinical analytics for chronic disease management. Rimidi is now offering a new application to help support clinics during the new COVID-19 outbreak. The app works to screen patients for symptoms or risk factors before they come into the healthcare system. With this enhanced pre-screening, clinics can identify at-risk patients earlier in the process and take the necessary precautions to properly deal with the situation. Rimidi is working closely with the CDC to ensure the accuracy of questions at a time when information on the virus is changing daily. Survey questions are no longer just for those who have travelled internationally, but for everyone experiencing symptoms as there have now been cases of community spread. The app now works off information regarding symptoms, exposure risk, and travel to identify those who may be at risk. Rimidi is working to keep their COVID-19 survey as short and simple as possible. Individuals with an appointment will get a text reminding them of their appointment and a link to complete the survey. The survey is web-based to ensure it will function on all devices. If the individual is considered to be at risk, they will be given a number to contact on the next actions they should take. Listen to the podcast to learn about: Where Rimidi is being rolled out Identifying and dealing with patients who may have COVID-19 Things that have changed in screening as we learn more about the virus How the app works to identify at-risk individuals The user experience with Rimidi Survey questions that Rimidi uses to identify COVID-19 no full 26 4e46fb8e-8a93-469f-8398-c8147a41d500 How is Project Polaris Improving Patient Satisfaction? Learn more about Greenway Health by visiting https://www.greenwayhealth.com/

]]> Sun, 8 Mar 2020 21:28:45 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Greenway Health by visiting https://www.greenwayhealth.com/

]]> How is Project Polaris Improving Patient Satisfaction? Codrin S Arsene 00:28:01 Today’s guest is Kali Durgampudi, chief technology and innovation officer at Greenway Health, a leading health information technology and services provider. He is working on Project Polaris, a technology which uses machine learning, AI, and natural language processing to save doctors time, increase their productivity, and improve patient satisfaction. This technology functions as a next generation electronic medical record, which reduces physician burden through machine learning that allows the doctor to focus more on the patient and less on paperwork. The interaction between patient and doctor will be recorded with patient consent, where the speech is converted to text and that text is converted to data. The goal with this technology is to reduce the amount of time physicians have to spend on documentation, as well as schedule follow-up appointments, send referrals, and order prescriptions. Long-term goals are to completely eliminate the need for doctors to complete documentation themselves, as well as scale all benefits to continue even if there is no physical interaction between patient and doctor. Listen to the podcast to learn about: How interaction will work between patient and doctor using this technology and its role in patient satisfaction The level of technology currently on the market How patient consent will work Common objections to machine learning and AI and their rebuttals How machine learning can be integrated with telemedicine Where Kali sees the healthcare industry in the next decade Today’s guest is Kali Durgampudi, chief technology and innovation officer at Greenway Health, a leading health information technology and services provider. He is working on Project Polaris, a technology which uses machine learning, AI, and natural language processing to save doctors time, increase their productivity, and improve patient satisfaction. This technology functions as a next generation electronic medical record, which reduces physician burden through machine learning that allows the doctor to focus more on the patient and less on paperwork. The interaction between patient and doctor will be recorded with patient consent, where the speech is converted to text and that text is converted to data. The goal with this technology is to reduce the amount of time physicians have to spend on documentation, as well as schedule follow-up appointments, send referrals, and order prescriptions. Long-term goals are to completely eliminate the need for doctors to complete documentation themselves, as well as scale all benefits to continue even if there is no physical interaction between patient and doctor. Listen to the podcast to learn about: How interaction will work between patient and doctor using this technology and its role in patient satisfaction The level of technology currently on the market How patient consent will work Common objections to machine learning and AI and their rebuttals How machine learning can be integrated with telemedicine Where Kali sees the healthcare industry in the next decade no full 24 b3739710-9f06-4d91-9109-ed0456eff05f Identifying Clinical and Social Needs with Clinify Learn more about Clinify by visiting https://www.clinifyhealth.com/

]]> Thu, 20 Feb 2020 21:47:44 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about Clinify by visiting https://www.clinifyhealth.com/

]]> Identifying Clinical and Social Needs with Clinify Codrin S Arsene 00:30:26 Today’s guest is Nate Pelzer, founder of Clinify. Clinify is a cloud-based health analytics platform that combines socioeconomic factors with applied health signals and machine learning, allowing providers to improve patient outcomes through enhanced communication and personalized care. Clinify uses a combination of data points and facts given directly by the patient regarding the state of their health and socioeconomic situation, giving providers a better understanding of their needs from a clinical and social perspective. With a focus on the most common and chronic conditions, providers are able to see through the noise and offer individualized care. Providers using the Clinify platform have seen a decrease in no-shows and ER readmissions, and an improvement in preventative care as well as in-clinic patient experience. Through the promotion of health and wellness plans individualized for each patient’s socioeconomic situation, Clinify helps providers offer the best care possible, especially for those in underserved areas. Listen to the podcast to learn about: The ties between patient health outcomes and socioeconomic factors Accounting for bias in a health setting Patient engagement methods The dangers of overreliance solely on older data The benefits of partnering with third party agencies to deliver care The positive impact on quality of care through leveraging technological and data-based solutions Lesser known correlations between certain conditions and socioeconomic factors Learn more about Clinify by visiting: https://www.clinifyhealth.com/ Today’s guest is Nate Pelzer, founder of Clinify. Clinify is a cloud-based health analytics platform that combines socioeconomic factors with applied health signals and machine learning, allowing providers to improve patient outcomes through enhanced communication and personalized care. Clinify uses a combination of data points and facts given directly by the patient regarding the state of their health and socioeconomic situation, giving providers a better understanding of their needs from a clinical and social perspective. With a focus on the most common and chronic conditions, providers are able to see through the noise and offer individualized care. Providers using the Clinify platform have seen a decrease in no-shows and ER readmissions, and an improvement in preventative care as well as in-clinic patient experience. Through the promotion of health and wellness plans individualized for each patient’s socioeconomic situation, Clinify helps providers offer the best care possible, especially for those in underserved areas. Listen to the podcast to learn about: The ties between patient health outcomes and socioeconomic factors Accounting for bias in a health setting Patient engagement methods The dangers of overreliance solely on older data The benefits of partnering with third party agencies to deliver care The positive impact on quality of care through leveraging technological and data-based solutions Lesser known correlations between certain conditions and socioeconomic factors Learn more about Clinify by visiting: https://www.clinifyhealth.com/ no full 25 3d1d2e66-fe65-4a07-928d-80c71b4ce398 Will Novoheart Make Animal Testing Obsolete? Learn more about Novoheart by visiting http://www.novoheart.com/global/

]]> Thu, 24 Oct 2019 22:55:13 +0000 codrin.arsene@digitalauthority.me (Kevin Costa, Codrin Arsene) http://www.healthcareweekly.com Learn more about Novoheart by visiting http://www.novoheart.com/global/

]]> Will Novoheart Make Animal Testing Obsolete? Kevin Costa, Codrin Arsene 00:32:46 In this episode, Codrin Arsene is joined by Kevin Costa. He is the Co-Founder and Chief Scientific Officer of Novoheart, a company that creates three-dimensional heart constructs which drug manufacturers can use to test out various drugs and treatments. The current drug development process can take ten years or more to complete. Kevin describes this very inefficient process and the costs incurred by manufacturers. He talks about the inaccurate results that testing animals provides and Novoheart’s offering of a much more reliable solution. The potential impact on medicine and healthcare by developing heart constructs that are specific to an individual patient is enormous. Kevin says that right now the costs may be prohibitive but explains that it is completely doable. Listen to the podcast to learn about: How Novoheart works and how they build their hearts Experiments and tests that are happening with Novoheart today Recent studies published by Novoheart Questions from scientists that Novoheart could address How specific the human tissue construct can be Limitations in this field In this episode, Codrin Arsene is joined by Kevin Costa. He is the Co-Founder and Chief Scientific Officer of Novoheart, a company that creates three-dimensional heart constructs which drug manufacturers can use to test out various drugs and treatments. The current drug development process can take ten years or more to complete. Kevin describes this very inefficient process and the costs incurred by manufacturers. He talks about the inaccurate results that testing animals provides and Novoheart’s offering of a much more reliable solution. The potential impact on medicine and healthcare by developing heart constructs that are specific to an individual patient is enormous. Kevin says that right now the costs may be prohibitive but explains that it is completely doable. Listen to the podcast to learn about: How Novoheart works and how they build their hearts Experiments and tests that are happening with Novoheart today Recent studies published by Novoheart Questions from scientists that Novoheart could address How specific the human tissue construct can be Limitations in this field novoheart, three-dimensional heart constructs, heart technology no full 23 13825757-4ce2-414b-be3a-c48e5e911c8d Is Artificial Intelligence the Future of Medical Quality Testing? Learn more about Qualitest by visiting https://qualitestgroup.com/

]]> Fri, 11 Oct 2019 21:26:05 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Neri Lavi) http://www.healthcareweekly.com Learn more about Qualitest by visiting https://qualitestgroup.com/

]]> Is Artificial Intelligence the Future of Medical Quality Testing? Codrin Arsene, Neri Lavi 00:36:44 Today’s guest is Neri Lavi. He serves as Managing Director in the United States for Qualitest, the largest quality engineering company in the world. In the US, most of Qualitest’s business activities revolve around the healthcare industry. Neri describes what to know before testing a device for V&V approval. He talks about the most common challenges that device manufacturers have to deal with, paying special attention to documentation and access. We also learn about the different areas that AI can be used in. In today's Healthcare Weekly episode, Neri talks about the three groups in healthcare that can benefit from testing through the use of artificial intelligence. He explains how AI can help with QA testing and takes us through relevant examples before giving his thoughts on data breaches in the medical industry. Listen to the podcast to learn about: An overview of Qualitest Common challenges faced by medical device manufacturers How artificial intelligence is leveraged in quality testing The usefulness of machine learning for the QA discipline Artificial intelligence use cases for healthcare solutions Common software development mistakes that lead to data breaches Underlying technologies that help companies get better at testing Today’s guest is Neri Lavi. He serves as Managing Director in the United States for Qualitest, the largest quality engineering company in the world. In the US, most of Qualitest’s business activities revolve around the healthcare industry. Neri describes what to know before testing a device for V&V approval. He talks about the most common challenges that device manufacturers have to deal with, paying special attention to documentation and access. We also learn about the different areas that AI can be used in. In today's Healthcare Weekly episode, Neri talks about the three groups in healthcare that can benefit from testing through the use of artificial intelligence. He explains how AI can help with QA testing and takes us through relevant examples before giving his thoughts on data breaches in the medical industry. Listen to the podcast to learn about: An overview of Qualitest Common challenges faced by medical device manufacturers How artificial intelligence is leveraged in quality testing The usefulness of machine learning for the QA discipline Artificial intelligence use cases for healthcare solutions Common software development mistakes that lead to data breaches Underlying technologies that help companies get better at testing quality assurance in healthcare, artificial intelligence healthcare, ai in healthcare no full 22 472f4667-7017-4bd5-9877-94dbadc95ca3 Keeping Employees Healthy with Virgin Pulse Learn more about Virgin Pulse by visiting https://www.virginpulse.com/

]]> Tue, 8 Oct 2019 17:47:48 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Rajiv Kumar) http://www.healthcareweekly.com Learn more about Virgin Pulse by visiting https://www.virginpulse.com/

]]> Keeping Employees Healthy with Virgin Pulse Codrin Arsene, Rajiv Kumar 00:51:58 Today we're chatting with Rajiv Kumar, Chief Medical Officer and President of the Virgin Pulse Institute. Virgin Pulse is the largest employee heath and well-being company in the world. They have a high-tech approach to engaging employees who work for large corporations to prevent health issues. Virgin Pulse has taken health and well-being and boiled it down to what Rajiv believes is the root of everything they want to accomplish. This root is the daily routine of employees, and Rajiv explains how Virgin Pulse influences this to improve lives. He also gives insight to the platform the company has built to deliver this information. There are three compelling pieces that Virgin Pulse has implemented in their platform that retain users, and Rajiv reveals what they are. He says that Virgin Pulse has been able to demonstrate meaningful outcomes year after year, which has allowed them to cultivate the sizable customer base that they have. Listen to the podcast to learn about: The alignment of Virgin Pulse’s mission and its conglomerate How the company is able to keep employees happy and healthy Sharing data points with physicians and employers Usage rates of the Virgin Pulse platform Measurable impacts that Virgin Pulse has on employees Generational differences in data Participation rate variation between genders Virgin Pulse’s acquisition of SimplyWell Today we're chatting with Rajiv Kumar, Chief Medical Officer and President of the Virgin Pulse Institute. Virgin Pulse is the largest employee heath and well-being company in the world. They have a high-tech approach to engaging employees who work for large corporations to prevent health issues. Virgin Pulse has taken health and well-being and boiled it down to what Rajiv believes is the root of everything they want to accomplish. This root is the daily routine of employees, and Rajiv explains how Virgin Pulse influences this to improve lives. He also gives insight to the platform the company has built to deliver this information. There are three compelling pieces that Virgin Pulse has implemented in their platform that retain users, and Rajiv reveals what they are. He says that Virgin Pulse has been able to demonstrate meaningful outcomes year after year, which has allowed them to cultivate the sizable customer base that they have. Listen to the podcast to learn about: The alignment of Virgin Pulse’s mission and its conglomerate How the company is able to keep employees happy and healthy Sharing data points with physicians and employers Usage rates of the Virgin Pulse platform Measurable impacts that Virgin Pulse has on employees Generational differences in data Participation rate variation between genders Virgin Pulse’s acquisition of SimplyWell virgin pulse, wearable technology, enterprise healthcare no full 21 13eef164-bcfe-431c-b2ae-e64176570021 Streamlining the Healthcare Licensing Process with BlocHealth Learn more about BlocHealth by visiting https://blochealth.com/

]]> Fri, 20 Sep 2019 21:08:10 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Learn more about BlocHealth by visiting https://blochealth.com/

]]> Streamlining the Healthcare Licensing Process with BlocHealth Codrin S Arsene 00:34:17 Today’s podcast guest is Jared Taylor. He is the CEO and co-founder of BlocHealth, which is a blockchain-based healthcare company taking on the licensing and credentialing process in the industry. BlocHealth has created a solution that will streamline this entire process. BlocHealth leverages a universal common application and blockchain technology to make the process go much faster without sacrificing security. Jared shares the roles of these two aspects and provides an explanation of how they work together to relieve healthcare providers of somewhat tedious activities. Getting providers to update their information readily is tough, but BlocHealth makes this easy by alerting them when licenses expire. Reducing incomplete applications along with getting applications back faster are areas where Jared believes BlocChain can alter the healthcare landscape for the better. Listen to the podcast to learn about: How BlocHealth works and its desired outcome The biggest challenges of healthcare in the United States Verification in the healthcare industry Gaps in legislation that need to be overcome by BlocHealth The value proposition of BlocHealth Cost reduction while staying aligned with policies The current status of BlocHealth Obstacles faced by the whole blockchain industry Today’s podcast guest is Jared Taylor. He is the CEO and co-founder of BlocHealth, which is a blockchain-based healthcare company taking on the licensing and credentialing process in the industry. BlocHealth has created a solution that will streamline this entire process. BlocHealth leverages a universal common application and blockchain technology to make the process go much faster without sacrificing security. Jared shares the roles of these two aspects and provides an explanation of how they work together to relieve healthcare providers of somewhat tedious activities. Getting providers to update their information readily is tough, but BlocHealth makes this easy by alerting them when licenses expire. Reducing incomplete applications along with getting applications back faster are areas where Jared believes BlocChain can alter the healthcare landscape for the better. Listen to the podcast to learn about: How BlocHealth works and its desired outcome The biggest challenges of healthcare in the United States Verification in the healthcare industry Gaps in legislation that need to be overcome by BlocHealth The value proposition of BlocHealth Cost reduction while staying aligned with policies The current status of BlocHealth Obstacles faced by the whole blockchain industry no full 20 0a44fbff-6401-49b6-b8d2-834f21e1dcee Smart hospital beds that can save lives? Yes, they exist! Learn more about EarlySense by visiting https://www.earlysense.com/

]]> Thu, 12 Sep 2019 21:15:38 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Matt Johnson) http://www.healthcareweekly.com Learn more about EarlySense by visiting https://www.earlysense.com/

]]> Smart hospital beds that can save lives? Yes, they exist! Codrin Arsene, Matt Johnson 00:29:47 Matt Johnson is the CEO of EarlySense and our guest in this podcast episode. The company makes a contact-free continuous patient monitor that turns any bed into a smart bed. Their clients are typically hospitals and nursing facilities, along with some home applications, too. In a typical day at a hospital, heart and respiratory rates are collected from patients about six times per day. EarlySense can collect this data twice per second, giving an earlier indication of patient deterioration that allows nurses and doctors to react quickly. The goal of EarlySense’s work in reducing deterioration events and improving patient outcomes is to make hospital care more predictable. From this, hospitals will perform much better overall. Matt hopes that within a few years, unmonitored beds will be on every hospital’s list of problems to solve. Listen to the podcast to learn about: What EarlySense does Data points that are collected from patients by EarlySense How a home-use experiment of EarlySense went Study results that support the use of EarlySense Hospitals being able to make more money by complying with Medicare EarlySense’s partnership with Hill-Rom Where Matt sees his company and the industry going in five years Matt Johnson is the CEO of EarlySense and our guest in this podcast episode. The company makes a contact-free continuous patient monitor that turns any bed into a smart bed. Their clients are typically hospitals and nursing facilities, along with some home applications, too. In a typical day at a hospital, heart and respiratory rates are collected from patients about six times per day. EarlySense can collect this data twice per second, giving an earlier indication of patient deterioration that allows nurses and doctors to react quickly. The goal of EarlySense’s work in reducing deterioration events and improving patient outcomes is to make hospital care more predictable. From this, hospitals will perform much better overall. Matt hopes that within a few years, unmonitored beds will be on every hospital’s list of problems to solve. Listen to the podcast to learn about: What EarlySense does Data points that are collected from patients by EarlySense How a home-use experiment of EarlySense went Study results that support the use of EarlySense Hospitals being able to make more money by complying with Medicare EarlySense’s partnership with Hill-Rom Where Matt sees his company and the industry going in five years smart bed, hospital technologies no full 19 0313486f-422d-48a7-a491-c821f4933eef Can healthcare analytics actually help with chronic disease management? One CEO say YES. Learn more about Rimidi by visiting https://rimidi.com/

]]> Sat, 31 Aug 2019 01:49:31 +0000 codrin.arsene@digitalauthority.me (Rimidi, Codrin Arsene, josh claman) http://www.healthcareweekly.com Learn more about Rimidi by visiting https://rimidi.com/

]]> Can healthcare analytics actually help with chronic disease management? One CEO say YES. Rimidi, Codrin Arsene, josh claman 00:33:52 Rimidi is a digital health company that provides software and clinical analytics for chronic disease management. The CEO of Rimidi, Josh Claman, is on the podcast today to educate us about the platform. Healthcare is currently a reactive system that is episodic and in-clinic. To manage chronic diseases effectively, Josh insists that we need to move towards an approach that virtualizes healthcare and delivers it to where the patient is. He explains how Rimidi can accomplish this. Rimidi does not want to further fragment healthcare. They don’t want an app that just cares for hypertension or diabetes; they want to treat patients as patients. Josh tells us how higher-risk patients with multiple issues can be treated holistically. Listen to the podcast to learn about: Rimidi’s mission to reshape healthcare Success that Josh has seen when Rimidi is used Addressing patient compliance and adherence to medical protocol Creating a partnership with Lilly Servicing the cardiovascular disease market with Rimidi The lack of integration between certain technological solutions Other areas that Josh thinks can be improved in healthcare Rimidi is a digital health company that provides software and clinical analytics for chronic disease management. The CEO of Rimidi, Josh Claman, is on the podcast today to educate us about the platform. Healthcare is currently a reactive system that is episodic and in-clinic. To manage chronic diseases effectively, Josh insists that we need to move towards an approach that virtualizes healthcare and delivers it to where the patient is. He explains how Rimidi can accomplish this. Rimidi does not want to further fragment healthcare. They don’t want an app that just cares for hypertension or diabetes; they want to treat patients as patients. Josh tells us how higher-risk patients with multiple issues can be treated holistically. Listen to the podcast to learn about: Rimidi’s mission to reshape healthcare Success that Josh has seen when Rimidi is used Addressing patient compliance and adherence to medical protocol Creating a partnership with Lilly Servicing the cardiovascular disease market with Rimidi The lack of integration between certain technological solutions Other areas that Josh thinks can be improved in healthcare medical protocols, healthtech, clinical software, patient compliance no full 18 af5adcad-13f7-43b6-955d-b3349a5ae367 Will blockchain change the global healthcare industry? Learn more about Pharmeum by visiting https://pharmeum.io/

]]> Wed, 14 Aug 2019 10:00:05 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Zain Rana) http://www.healthcareweekly.com Learn more about Pharmeum by visiting https://pharmeum.io/

]]> Will blockchain change the global healthcare industry? Codrin Arsene, Zain Rana 00:31:05 Zain Rana, the CEO of Pharmeum, joins the podcast in this episode. Pharmeum claims to be the first blockchain company in artificial intelligence solutions for healthcare. Zain tells us that Pharmeum is trying to create a more intelligent healthcare system. By doing so, patients will be able to access healthcare more affordably through their smartphone anywhere in the world. He educates us on why blockchain is useful in this application. Doctors often face challenges when identifying patients on a global level. Furthermore, accessing and transferring patient records is another difficult task. Zain discusses how blockchain can make both of these processes much easier. Listen to the podcast to learn about: How Pharmeum works and who it is intended for Medical errors that can be reduced by using Pharmeum The application of blockchain in this use case The steps to become a part of the Pharmeum network Information blocking and patient identification Algorithms that Pharmeum is utilizing Sources of collecting patient data Pharmeum’s push for change in the healthcare industry Zain Rana, the CEO of Pharmeum, joins the podcast in this episode. Pharmeum claims to be the first blockchain company in artificial intelligence solutions for healthcare. Zain tells us that Pharmeum is trying to create a more intelligent healthcare system. By doing so, patients will be able to access healthcare more affordably through their smartphone anywhere in the world. He educates us on why blockchain is useful in this application. Doctors often face challenges when identifying patients on a global level. Furthermore, accessing and transferring patient records is another difficult task. Zain discusses how blockchain can make both of these processes much easier. Listen to the podcast to learn about: How Pharmeum works and who it is intended for Medical errors that can be reduced by using Pharmeum The application of blockchain in this use case The steps to become a part of the Pharmeum network Information blocking and patient identification Algorithms that Pharmeum is utilizing Sources of collecting patient data Pharmeum’s push for change in the healthcare industry no full 17 d7984c64-6af0-4c39-9a6d-8b5294743bf0 Healthcare Investments with Dan Malven, Managing Director at 4490 Ventures Dan Malven is today’s podcast guest. He is the Managing Director at 4490 Ventures, an investment group out of Madison, Wisconsin.

]]> Mon, 12 Aug 2019 00:16:48 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Dan Malven is today’s podcast guest. He is the Managing Director at 4490 Ventures, an investment group out of Madison, Wisconsin.

]]> Healthcare Investments with Dan Malven, Managing Director at 4490 Ventures Codrin S Arsene 00:46:41 Dan Malven is today’s podcast guest. He is the Managing Director at 4490 Ventures, an investment group out of Madison, Wisconsin. Investments that involve piecing data together have been of high interest to Dan as of late. He explains what this process looks like and comments on FDA-approved algorithms. Another investment that Dan is excited about features a new way to pay for healthcare patients. When trying to get a consumer to change their behavior, the new solution must be drastically better than the status quo. This hurdle can be a bit easier to overcome when selling directly to businesses, which leads Dan into his thoughts on increasing margin power. Listen to the podcast to learn about: * Companies that 4490 Ventures has invested in. * Dealing with the FDA. * Selection criteria for investments at 4490 Ventures. * What venture capitalists care the most when investing in healthcare startups. Dan Malven is today’s podcast guest. He is the Managing Director at 4490 Ventures, an investment group out of Madison, Wisconsin. Investments that involve piecing data together have been of high interest to Dan as of late. He explains what this process looks like and comments on FDA-approved algorithms. Another investment that Dan is excited about features a new way to pay for healthcare patients. When trying to get a consumer to change their behavior, the new solution must be drastically better than the status quo. This hurdle can be a bit easier to overcome when selling directly to businesses, which leads Dan into his thoughts on increasing margin power. Listen to the podcast to learn about: * Companies that 4490 Ventures has invested in. * Dealing with the FDA. * Selection criteria for investments at 4490 Ventures. * What venture capitalists care the most when investing in healthcare startups. no full 16 fb3a61fb-038d-418b-900d-cd43222df5cf Can we eliminate medical device recall malfunctions? Soom is on a mission to do just that. Learn more about Charlie Kim and Soom by visiting https://www.soom.com/

]]> Tue, 6 Aug 2019 13:00:01 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Charlie Kim) http://www.healthcareweekly.com Learn more about Charlie Kim and Soom by visiting https://www.soom.com/

]]> Can we eliminate medical device recall malfunctions? Soom is on a mission to do just that. Codrin Arsene, Charlie Kim 00:37:19 Today we talk to Charlie Kim, CEO @ Soom, a health tech startup that offers medical device manufacturers a simple solution that enables master data accuracy, data governance, and error correction. This means eliminating backlogs in the supply chain caused by data errors, improving IT efficiency and productivity, maintaining regulatory compliance, avoiding adverse events like product recalls, and, most importantly, improving patient safety. Listen to the podcast to learn about: The Soom App & how customers can get real-time notifications about device recalls How device manufactures can increase transparency and efficiency in the supply chain process How Soom improves inoperability among private and open data systems Today we talk to Charlie Kim, CEO @ Soom, a health tech startup that offers medical device manufacturers a simple solution that enables master data accuracy, data governance, and error correction. This means eliminating backlogs in the supply chain caused by data errors, improving IT efficiency and productivity, maintaining regulatory compliance, avoiding adverse events like product recalls, and, most importantly, improving patient safety. Listen to the podcast to learn about: The Soom App & how customers can get real-time notifications about device recalls How device manufactures can increase transparency and efficiency in the supply chain process How Soom improves inoperability among private and open data systems interoperability in healthcare, data security healthcare, medical devices no full 15 9b967fd8-016d-4fa2-ad7f-5ca0b7f72215 Is telemedicine the secret to living healthier and longer lives? Learn more about Doctor Tong & Doctor on Demand at https://www.doctorondemand.com/

]]> Sun, 4 Aug 2019 18:49:58 +0000 codrin.arsene@digitalauthority.me (Ian Tong, Codrin Arsene) http://www.healthcareweekly.com Learn more about Doctor Tong & Doctor on Demand at https://www.doctorondemand.com/

]]> Is telemedicine the secret to living healthier and longer lives? Ian Tong, Codrin Arsene 00:53:26 Meet doctor Ian Tong, Chief Medical Officer @ Doctor On Demand, a video consultation service that raised $74 million last year to scale up its operations and reach more patients. Doctor On Demand's telemedicine model is unique, hiring doctors full time versus tapping into the physician gig economy. Each doctor sees approximately 4 patients per hour. Listen to Doctor Tong to learn about: What makes Doctor on Demand different from all other telemedicine providers How Doctor on Demand has become one of the fastest growing telemedicine providers in the US Consumers' growing acceptance of telemedicine as a way of seeking medical assistance for everyday ailments. Meet doctor Ian Tong, Chief Medical Officer @ Doctor On Demand, a video consultation service that raised $74 million last year to scale up its operations and reach more patients. Doctor On Demand's telemedicine model is unique, hiring doctors full time versus tapping into the physician gig economy. Each doctor sees approximately 4 patients per hour. Listen to Doctor Tong to learn about: What makes Doctor on Demand different from all other telemedicine providers How Doctor on Demand has become one of the fastest growing telemedicine providers in the US Consumers' growing acceptance of telemedicine as a way of seeking medical assistance for everyday ailments. telemedicine, doctor on demand, telehealth no full 14 9af4e731-e68e-445c-84da-454f873e0b21 Can a smart pill dispenser improve pharma medical trial outcomes? Learn more about Dr James Burnstone & Elucid Mhealth by visiting www.elucid-mhealth.com

]]> Thu, 25 Jul 2019 20:59:38 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, James Burnstone) http://www.healthcareweekly.com Learn more about Dr James Burnstone & Elucid Mhealth by visiting www.elucid-mhealth.com

]]> Can a smart pill dispenser improve pharma medical trial outcomes? Codrin Arsene, James Burnstone 00:37:46 Meet Dr James Burnstone, CEO @ Elucid Mhealth, a Manchester-based technology company working to support patients to improve care. Elucid has developed a smart pill dispenser exclusively dedicated to medical trial management. The locked container can be used for solid oral dose medication and it electronically dispenses 1 or more doses. The container can be locked down remotely and it is paired to a single smartphone. Listen to the podcast to learn about: How Elucid smart pill dispenser works The market opportunity - and need - for smart dispensers in the clinical trial setting Early results from medical trials leveraging the Elucid solution Meet Dr James Burnstone, CEO @ Elucid Mhealth, a Manchester-based technology company working to support patients to improve care. Elucid has developed a smart pill dispenser exclusively dedicated to medical trial management. The locked container can be used for solid oral dose medication and it electronically dispenses 1 or more doses. The container can be locked down remotely and it is paired to a single smartphone. Listen to the podcast to learn about: How Elucid smart pill dispenser works The market opportunity - and need - for smart dispensers in the clinical trial setting Early results from medical trials leveraging the Elucid solution smart pill dispenser, healthcare iot, james burnstone, pharma trials, elucid mhealth no full 13 adcf020d-5343-4421-8f93-bc72c4c64c58 Can emerging tech help detect dementia at an early stage? learn more about Thomas Sawyer & Cognetivity by visiting www.cognetivity.com

]]> Wed, 17 Jul 2019 17:02:31 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Thomas Sawyer) http://www.healthcareweekly.com learn more about Thomas Sawyer & Cognetivity by visiting www.cognetivity.com

]]> Can emerging tech help detect dementia at an early stage? Codrin Arsene, Thomas Sawyer 00:40:32 Can an iPad application help detect dementia and Alzheimer's at an early stage? One healthcare startup is betting on it! Listen to doctor Thomas Sawyer, COO @ Cognetivity talk about an innovative digital platform platform (leveraging image recognition and Artificial Intelligence) that can detect brain deterioration to help patients and physicians define a course of treatment at an earlier stage. The startup can detect users' cognitive function and determine if it is within a normal range (or not!) by using Artificial Intelligence to make judgement calls and recommendations about patient's patterns of responses to the test. The company will take their solution to market at the end of 2019. In this podcast learn about: How Cognitivity works Who it is intended for Early trials & results Can an iPad application help detect dementia and Alzheimer's at an early stage? One healthcare startup is betting on it! Listen to doctor Thomas Sawyer, COO @ Cognetivity talk about an innovative digital platform platform (leveraging image recognition and Artificial Intelligence) that can detect brain deterioration to help patients and physicians define a course of treatment at an earlier stage. The startup can detect users' cognitive function and determine if it is within a normal range (or not!) by using Artificial Intelligence to make judgement calls and recommendations about patient's patterns of responses to the test. The company will take their solution to market at the end of 2019. In this podcast learn about: How Cognitivity works Who it is intended for Early trials & results digital therapeutics, alzheimer's, healthcare weekly, dementia, image recognition, artificial intelligence in healthcare no full 12 2007cd27-aac2-4e87-b6c5-b51f83bc3068 Can heart arrhythmia be diagnosed in time? A healthtech company has the answer. Check InfoBionic and Stuart Long @ infobionic.com

]]> Mon, 17 Jun 2019 17:20:08 +0000 codrin.arsene@digitalauthority.me (Stuart Long, Codrin Arsene) http://www.healthcareweekly.com Check InfoBionic and Stuart Long @ infobionic.com

]]> Can heart arrhythmia be diagnosed in time? A healthtech company has the answer. Stuart Long, Codrin Arsene 00:40:44 Join Codrin Arsene and Stuart Long, CEO @ Infobionic, a healthtech company that recently secured $50 Million in Financing to Support Continued Growth of the MoMe® Kardia System for Cardiac Arrhythmia Detection. MoMe® is an Apple mouse-like smart heart monitor which gives doctors and patients 24/7 access to ECG data collected on the go. The MoMe® device uses Artificial Intelligence to interpret massive amounts of data and provide actionable insights to physicians in order to improve the quality of care for patients all over the world. The MoMe remote cardiac monitoring platform was granted 501(k) clearance from the U.S. Food and Drug Administration in 2015. Learn: How MoMe works Why a remote afib device is the future of cardiac care Who can benefit from it Join Codrin Arsene and Stuart Long, CEO @ Infobionic, a healthtech company that recently secured $50 Million in Financing to Support Continued Growth of the MoMe® Kardia System for Cardiac Arrhythmia Detection. MoMe® is an Apple mouse-like smart heart monitor which gives doctors and patients 24/7 access to ECG data collected on the go. The MoMe® device uses Artificial Intelligence to interpret massive amounts of data and provide actionable insights to physicians in order to improve the quality of care for patients all over the world. The MoMe remote cardiac monitoring platform was granted 501(k) clearance from the U.S. Food and Drug Administration in 2015. Learn: How MoMe works Why a remote afib device is the future of cardiac care Who can benefit from it infobionic, afib device, heart health, afib, heart monitor no full 11 9feb90ae-c943-4758-8547-a86cef0d9c9a Can AI save lives and reduce hospital costs? One startup is betting on it! Sat, 8 Jun 2019 17:50:21 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene, Samir Manjure) http://www.healthcareweekly.com Can AI save lives and reduce hospital costs? One startup is betting on it! Codrin Arsene, Samir Manjure 00:40:40 In the latest episode of the HCW podcast, Codrin Arsene talks to Samir Manjure, CEO of KenSci, a healthtech company that provides automated insights to major hospitals and care facilities all over the US. KenSci helps hospitals predict the number of patients showing up at a hospital at any given point, the percentage of patients who will be committed & discharged and the percentage of patients who will return to a hospital in a given timeframe. Listen to this episode to learn how KenSci works, who it is intended for and the benefits hospitals and care facilities can experience by leveraging this new and exciting AI-driven technology. In the latest episode of the HCW podcast, Codrin Arsene talks to Samir Manjure, CEO of KenSci, a healthtech company that provides automated insights to major hospitals and care facilities all over the US. KenSci helps hospitals predict the number of patients showing up at a hospital at any given point, the percentage of patients who will be committed & discharged and the percentage of patients who will return to a hospital in a given timeframe. Listen to this episode to learn how KenSci works, who it is intended for and the benefits hospitals and care facilities can experience by leveraging this new and exciting AI-driven technology. artificial intelligence healthcare, ai for hospitals, predictive analytics healthcare no full 10 e89a1184-bd6b-4b3d-bda7-e2771e37e764 The tech for the lonely: How Care Coach helps the elderly manage their chronic conditions Thu, 23 May 2019 20:16:18 +0000 codrin.arsene@digitalauthority.me (Victor Wang, Codrin Arsene) http://www.healthcareweekly.com The tech for the lonely: How Care Coach helps the elderly manage their chronic conditions Victor Wang, Codrin Arsene 00:59:05 Meet Care Coach: the game-changing innovation for aging care that leverages the best of both human and technological capabilities. Care Coach is a smart assistant avatar assuring continuity of care, offering psychosocial support and assistance with the management of chronic conditions for the elderly. This unique avatar technology is used in patients' hospital rooms and homes to support them and provide companionship. Listen to Victor Wang, CEO @ Care.Coach talk about this innovative solution, how it works, who it is for and the myriad of use cases Care Coach can be leveraged for. Meet Care Coach: the game-changing innovation for aging care that leverages the best of both human and technological capabilities. Care Coach is a smart assistant avatar assuring continuity of care, offering psychosocial support and assistance with the management of chronic conditions for the elderly. This unique avatar technology is used in patients' hospital rooms and homes to support them and provide companionship. Listen to Victor Wang, CEO @ Care.Coach talk about this innovative solution, how it works, who it is for and the myriad of use cases Care Coach can be leveraged for. care.coach, tech support for the elderly, elderly care no full 9 a0d44cdd-825f-48d4-8e45-4f733c33e726 The rise of personalized healthcare through home blood testing Learn how Imaware has built a home test and robust user experience helping customers understand their condition on their own, without the help of a doctor or physician.

Defining and designing the final blood testing digital report took over 200 iterations, highlighting how crucial it is for companies to get the UX for a health product right.

The Canadian startup has already processed tens of thousands of test and has big plans for the future.

Check out today's guest at www.imaware.health

]]> Sat, 27 Apr 2019 02:21:36 +0000 codrin.arsene@digitalauthority.me (Jani Tuomi, Codrin Arsene) http://www.healthcareweekly.com Learn how Imaware has built a home test and robust user experience helping customers understand their condition on their own, without the help of a doctor or physician.

Defining and designing the final blood testing digital report took over 200 iterations, highlighting how crucial it is for companies to get the UX for a health product right.

The Canadian startup has already processed tens of thousands of test and has big plans for the future.

Check out today's guest at www.imaware.health

]]> The rise of personalized healthcare through home blood testing Jani Tuomi, Codrin Arsene 00:28:30 In this episode, Codrin Arsene talks to Jani Tuomi, one of the co-founders of imaware.coach, a blood testing platform which allows patients to test for celiac disease & Rheumatoid Arthritis from the comfort of their homes. The global health self-monitoring technology market will reach $19 billion by the end of 2019. In this episode, Codrin Arsene talks to Jani Tuomi, one of the co-founders of imaware.coach, a blood testing platform which allows patients to test for celiac disease & Rheumatoid Arthritis from the comfort of their homes. The global health self-monitoring technology market will reach $19 billion by the end of 2019. at home blood testing, rheumatoid arthritis, self-test kit, celiac disease, medical test results no full 8 3c9d2d6e-a2ca-41ce-9d8c-be936c825552 When AI saves lives: iCAD's FDA-cleared imaging solution & the Future of Healthcare Mon, 22 Apr 2019 03:29:54 +0000 codrin.arsene@digitalauthority.me (Michael Klein, Codrin Arsene) http://www.healthcareweekly.com When AI saves lives: iCAD's FDA-cleared imaging solution & the Future of Healthcare Michael Klein, Codrin Arsene 00:39:36 Listen to Codrin Arsene interview Michael Klein, the CEO @ iCAD, one of the few FDA-approved artificial intelligence solutions for radiologists. iCAD's AI analyzes hundreds of data-points to deliver powerful software solutions for breast tomosynthesis, breast density and 2D mammography. In simple terms, the iCAD software (Profound AI) analyzes mammogram images and correlates them to demographic data to produce cancer probability scores for radiologists. Whereas iCAD cannot officially 'diagnose' breast cancer, the software alerts radiologists of any abnormalities tied to mammogram images for further inspection. In the clinical trial which led to iCAD getting FDA approval, Profound AI was responsible for detecting 8% more cancers than the group of radiologists that analyzed the same data set. Listen to the podcast to learn about the history of iCAD, their current AI solution, new exciting features and functionalities iCAD plans to release later this year and the future of AI in healthcare. Listen to Codrin Arsene interview Michael Klein, the CEO @ iCAD, one of the few FDA-approved artificial intelligence solutions for radiologists. iCAD's AI analyzes hundreds of data-points to deliver powerful software solutions for breast tomosynthesis, breast density and 2D mammography. In simple terms, the iCAD software (Profound AI) analyzes mammogram images and correlates them to demographic data to produce cancer probability scores for radiologists. Whereas iCAD cannot officially 'diagnose' breast cancer, the software alerts radiologists of any abnormalities tied to mammogram images for further inspection. In the clinical trial which led to iCAD getting FDA approval, Profound AI was responsible for detecting 8% more cancers than the group of radiologists that analyzed the same data set. Listen to the podcast to learn about the history of iCAD, their current AI solution, new exciting features and functionalities iCAD plans to release later this year and the future of AI in healthcare. healthcare innovation, ai in healthcare, radiology, icad, artificial intelligence in healthcare, artificial intelligence radiology no full 7 7139e80e-7616-49a8-b356-c2c79d759374 Can telemedicine save lives? Short answer: absolutely Mon, 15 Apr 2019 23:34:45 +0000 codrin.arsene@digitalauthority.me (Joseph Truscelli, codrin arsene) http://www.healthcareweekly.com Can telemedicine save lives? Short answer: absolutely Joseph Truscelli, codrin arsene 00:51:01 Codrin Arsene talks to Joseph Truscelli, the CEO @ HelloAlvin, a leading telemedicine provider powered by Teladoc which is the oldest and largest telemedicine company In America.   Listen to this podcast and learn: How telemedicine works Who can use telemedicine The demographics of telemedicine users (spoiler alert: telehealth is very popular among women!) The future of telemedicine And much more... Codrin Arsene talks to Joseph Truscelli, the CEO @ HelloAlvin, a leading telemedicine provider powered by Teladoc which is the oldest and largest telemedicine company In America.   Listen to this podcast and learn: How telemedicine works Who can use telemedicine The demographics of telemedicine users (spoiler alert: telehealth is very popular among women!) The future of telemedicine And much more... teladoc, telemedicine, hello alvin, telemedicine solutions, how telemedicine works no full 6 1cb5ca4d-f802-4760-a7b8-50604116a272 Are hospitals ready to adopt cutting-edge technologies? One hospital CEO is! Thu, 4 Apr 2019 19:17:37 +0000 codrin.arsene@digitalauthority.me (Julie Knitter, Codrin Arsene, Larry Levine) http://www.healthcareweekly.com Are hospitals ready to adopt cutting-edge technologies? One hospital CEO is! Julie Knitter, Codrin Arsene, Larry Levine 00:27:16 Listen to Larry Levine, CEO @ President at Blythedale Children hospital talk about a series of assistive technologies that make a tremendous impact on delivering outstanding patient outcomes. In this special episode, we are also joined by Julie Knitter, Director of Blythedale’s Assistive Technology Program. We discuss the future of healthcare, challenges to technology adoption and how we, as a country, can work towards reducing the cost of medical care while improving patient outcomes. Blythedale is New York State’s only independent, specialty children’s hospital and one of only 14 pediatric specialty hospitals in the United States. Serving patients from birth through age 19, Blythedale has the combined staff, expertise and resources – including the largest pediatric therapy department in New York State – to provide exceptional comprehensive care for medically complex children and support for their families. Listen to Larry Levine, CEO @ President at Blythedale Children hospital talk about a series of assistive technologies that make a tremendous impact on delivering outstanding patient outcomes. In this special episode, we are also joined by Julie Knitter, Director of Blythedale’s Assistive Technology Program. We discuss the future of healthcare, challenges to technology adoption and how we, as a country, can work towards reducing the cost of medical care while improving patient outcomes. Blythedale is New York State’s only independent, specialty children’s hospital and one of only 14 pediatric specialty hospitals in the United States. Serving patients from birth through age 19, Blythedale has the combined staff, expertise and resources – including the largest pediatric therapy department in New York State – to provide exceptional comprehensive care for medically complex children and support for their families. hospital it, blythedale children hospital, hospital innovation no full 5 b3d8b1c6-8d9e-4414-870d-76c0395d9eb2 Can one bluetooth device + mobile app reduce stress and improve our quality of life? Wed, 20 Mar 2019 01:50:52 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Can one bluetooth device + mobile app reduce stress and improve our quality of life? Codrin S Arsene 00:38:56 In the latest episode of the Healthcare Weekly Podcast, Codrin Arsene talks to Deborah Rozman, CEO @ Heartmath, a health-tech company behind the bluetooth enabled device which uses science-based technology to help users take control of their lives. The Heartmath solution has been clinically proven to help patients reduce stress and anxiety by increasing their inner balance and self-security. In this episode, Codrin and Deborah talk about how emerging health technologies can improve productivity, a person's sense of self worth and, ultimately, one's quality of life. In the latest episode of the Healthcare Weekly Podcast, Codrin Arsene talks to Deborah Rozman, CEO @ Heartmath, a health-tech company behind the bluetooth enabled device which uses science-based technology to help users take control of their lives. The Heartmath solution has been clinically proven to help patients reduce stress and anxiety by increasing their inner balance and self-security. In this episode, Codrin and Deborah talk about how emerging health technologies can improve productivity, a person's sense of self worth and, ultimately, one's quality of life. artificial intelligence, health tech no full 4 a878f076-87d3-4bbc-9bd9-409a13bd978e Can Artificial Intelligence be the answer to improve quality of life & patient outcomes for Americans living with cancer? Fri, 1 Mar 2019 20:20:01 +0000 codrin.arsene@digitalauthority.me (Codrin S Arsene) http://www.healthcareweekly.com Can Artificial Intelligence be the answer to improve quality of life & patient outcomes for Americans living with cancer? Codrin S Arsene 00:44:48 In today's episode we speak with Sangeeta Agarwal, the CEO & Founder of Helpsy an artificial intelligence platform designed to help patients cope with cancer, follow treatment protocols and improve their quality of life. San, the customer facing AI bot, keeps track of patients' medicine, alerts patients in real time of potential side effects, manages their appointment schedule, and connects patients with their primary physicians in case of emergencies. Learn more about Sangeeta & Helpsy at helpsyhealth.com. In today's episode we speak with Sangeeta Agarwal, the CEO & Founder of Helpsy an artificial intelligence platform designed to help patients cope with cancer, follow treatment protocols and improve their quality of life. San, the customer facing AI bot, keeps track of patients' medicine, alerts patients in real time of potential side effects, manages their appointment schedule, and connects patients with their primary physicians in case of emergencies. Learn more about Sangeeta & Helpsy at helpsyhealth.com. no full 3 6d4f0d3f-1079-4a09-90a6-83d7f0edaf75 Can one app help people who suffer from depression, ADHD, sleep deprivation or jet lag? Fri, 1 Mar 2019 01:26:17 +0000 codrin.arsene@digitalauthority.me (Patrick Porter, Codrin Arsene) http://www.healthcareweekly.com Can one app help people who suffer from depression, ADHD, sleep deprivation or jet lag? Patrick Porter, Codrin Arsene 00:28:20 In this episode, we interview Doctor Patrick K. Porter, the creative mind behind BrainTap, a mobile app which restore users' natural balance so they can feel relaxed, rebooted and revitalized. The clinical methodology powering the app has proven successful in helping patients who suffer from depression, dementia or even a simple jet lag, recover faster and living fuller lives. Learn more about doctor Porter & BrainTap at https://braintaptech.com/ In this episode, we interview Doctor Patrick K. Porter, the creative mind behind BrainTap, a mobile app which restore users' natural balance so they can feel relaxed, rebooted and revitalized. The clinical methodology powering the app has proven successful in helping patients who suffer from depression, dementia or even a simple jet lag, recover faster and living fuller lives. Learn more about doctor Porter & BrainTap at https://braintaptech.com/ alzheimer's, healthcare weekly, health tech, depression, braintap no full 2 a43907de-8674-4822-bb33-a9faea881538 Can blockchain help pharma find better drug trial participants faster & patients monetize their medical data? Wed, 27 Feb 2019 00:29:00 +0000 codrin.arsene@digitalauthority.me (Codrin Arsene) http://www.healthcareweekly.com Can blockchain help pharma find better drug trial participants faster & patients monetize their medical data? Codrin Arsene 00:42:25 Codrin Arsene talks to Embleema CEO Robert Chu about the future of blockchain and how this technology will democratize patient data and help pharma companies improve their operational efficiency and speed up the drug discovery process. Codrin Arsene talks to Embleema CEO Robert Chu about the future of blockchain and how this technology will democratize patient data and help pharma companies improve their operational efficiency and speed up the drug discovery process. blockchain in healthcare no full 1